{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T23:48:09Z","timestamp":1793404089895,"version":"4.5.0"},"reference-count":380,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,2,4]],"date-time":"2022-02-04T00:00:00Z","timestamp":1643932800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Mol. Biosci."],"abstract":"<jats:p>Pemphigus represents a group of rare and severe autoimmune intra-epidermal blistering diseases affecting the skin and mucous membranes. These painful and debilitating diseases are driven by the production of autoantibodies that are mainly directed against the desmosomal adhesion proteins, desmoglein 3 (Dsg3) and desmoglein 1 (Dsg1). The search to define underlying triggers for anti-Dsg-antibody production has revealed genetic, environmental, and possible vaccine-driven factors, but our knowledge of the processes underlying disease initiation and pathology remains incomplete. Recent studies point to an important role of T cells in supporting auto-antibody production; yet the involvement of the myeloid compartment remains unexplored. Clinical management of pemphigus is beginning to move away from broad-spectrum immunosuppression and towards B-cell-targeted therapies, which reduce many patients\u2019 symptoms but can have significant side effects. Here, we review the latest developments in our understanding of the predisposing factors\/conditions of pemphigus, the underlying pathogenic mechanisms, and new and emerging therapies to treat these devastating diseases.<\/jats:p>","DOI":"10.3389\/fmolb.2021.808536","type":"journal-article","created":{"date-parts":[[2022,2,4]],"date-time":"2022-02-04T16:19:56Z","timestamp":1643991596000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":37,"title":["Autoimmune Pemphigus: Latest Advances and Emerging Therapies"],"prefix":"10.3389","volume":"8","author":[{"given":"Yen Loo","family":"Lim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerome","family":"Bohelay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sho","family":"Hanakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Musette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baptiste","family":"Janela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,2,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1001\/archdermatol.2009.9","article-title":"ELISA Testing of Anti-desmoglein 1 and 3 Antibodies in the Management of Pemphigus","volume":"145","author":"Abasq","year":"2009","journal-title":"Arch. Dermatol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1111\/j.1365-2133.2009.09386.x","article-title":"The Familial Feature of Tunisian Endemic Pemphigus Foliaceus","volume":"161","author":"Abida","year":"2009","journal-title":"Br. J. Dermatol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1067\/s0190-9622(03)00852-1","article-title":"Analyses of Autoantigens in a New Form of Endemic Pemphigus Foliaceus in Colombia","volume":"49","author":"Abr\u00e8u-Velez","year":"","journal-title":"J. Am. Acad. Dermatol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1067\/s0190-9622(03)00851-x","article-title":"A Unique Form of Endemic Pemphigus in Northern Colombia","volume":"49","author":"Abr\u00e8u-Velez","year":"","journal-title":"J. Am. Acad. Dermatol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1001\/archderm.134.10.1300-a","article-title":"Pemphigus Foliaceus Induced by Psoralen-UV-A","volume":"134","author":"Aghassi","year":"1998","journal-title":"Arch. Dermatol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/j.1365-4362.1984.tb05688.x","article-title":"Pemphigus Vegetans","volume":"23","author":"Razzaque Ahmed","year":"1984","journal-title":"Int. J. Dermatol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"5056","DOI":"10.1073\/pnas.88.11.5056","article-title":"Major Histocompatibility Complex Haplotypes and Class II Genes in Non-jewish Patients with Pemphigus Vulgaris","volume":"88","author":"Ahmed","year":"1991","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1111\/exd.13106","article-title":"Monopathogenic vs Multipathogenic Explanations of Pemphigus Pathophysiology","volume":"25","author":"Ahmed","year":"2016","journal-title":"Exp. Dermatol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1111\/1523-1747.ep12472348","article-title":"Subclass Reactivity of Pemphigus Foliaceus Autoantibodies with Recombinant Human Desmoglein","volume":"100","author":"Allen","year":"1993","journal-title":"J. Invest. Dermatol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/jid.2011.390","article-title":"Desmoglein as a Target in Skin Disease and beyond","volume":"132","author":"Amagai","year":"2012","journal-title":"J. Invest. Dermatol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/0092-8674(91)90360-B","article-title":"Autoantibodies against a Novel Epithelial Cadherin in Pemphigus Vulgaris, a Disease of Cell Adhesion","volume":"67","author":"Amagai","year":"1991","journal-title":"Cell"},{"key":"B12","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1172\/JCI115968","article-title":"Autoantibodies against the Amino-Terminal Cadherin-like Binding Domain of Pemphigus Vulgaris Antigen Are Pathogenic","volume":"90","author":"Amagai","year":"1992","journal-title":"J. Clin. Invest."},{"key":"B13","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1111\/1523-1747.ep12606168","article-title":"Antigen-Specific Immunoadsorption of Pathogenic Autoantibodies in Pemphigus Foliaceus","volume":"104","author":"Amagai","year":"1995","journal-title":"J. Invest. Dermatol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1172\/JCI3647","article-title":"Antibodies against Desmoglein 3 (Pemphigus Vulgaris Antigen) Are Present in Sera from Patients with Paraneoplastic Pemphigus and Cause Acantholysis In Vivo in Neonatal Mice","volume":"102","author":"Amagai","year":"1998","journal-title":"J. Clin. Invest."},{"key":"B15","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1046\/j.1365-2133.1999.02752.x","article-title":"Usefulness of Enzyme-Linked Immunosorbent Assay Using Recombinant Desmogleins 1 and 3 for Serodiagnosis of Pemphigus","volume":"140","author":"Amagai","year":"1999","journal-title":"Br. J. Dermatol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1172\/JCI8748","article-title":"Use of Autoantigen-Knockout Mice in Developing an Active Autoimmune Disease Model for Pemphigus","volume":"105","author":"Amagai","year":"2000","journal-title":"J. Clin. Invest."},{"key":"B17","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.jaad.2008.09.052","article-title":"A Randomized Double-Blind Trial of Intravenous Immunoglobulin for Pemphigus","volume":"60","author":"Amagai","year":"2009","journal-title":"J. Am. Acad. Dermatol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1111\/j.1365-3164.2009.00831.x","article-title":"The Molecular Logic of Pemphigus and Impetigo: the Desmoglein story","volume":"20","author":"Amagai","year":"2009","journal-title":"Vet. Dermatol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.3389\/fimmu.2018.01190","article-title":"Non-Desmoglein Antibodies in Patients with Pemphigus Vulgaris","volume":"9","author":"Amber","year":"2018","journal-title":"Front. Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/j.1365-4362.1985.tb05349.x","article-title":"Pemphigus Erythematosus","volume":"24","author":"Amerian","year":"1985","journal-title":"Int. J. Dermatol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1056\/NEJM198205203062001","article-title":"Induction of Pemphigus in Neonatal Mice by Passive Transfer of IgG from Patients with the Disease","volume":"306","author":"Anhalt","year":"1982","journal-title":"N. Engl. J. Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1056\/NEJM199012203232503","article-title":"Paraneoplastic Pemphigus","volume":"323","author":"Anhalt","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/j.1087-0024.2004.00832.x","article-title":"Paraneoplastic Pemphigus","volume":"9","author":"Anhalt","year":"2004","journal-title":"J. Invest. Dermatol. Symp. Proc."},{"key":"B24","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/1346-8138.12675","article-title":"Cooperative Group on Fogo Selvagem ResearchUpdate on Fogo Selvagem, an Endemic Form of Pemphigus Foliaceus","volume":"42","author":"Aoki","year":"2015","journal-title":"J. Dermatol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/j.1365-2133.2004.06056.x","article-title":"A Mouse Model of Pemphigus Vulgaris by Adoptive Transfer of Naive Splenocytes from Desmoglein 3 Knockout Mice","volume":"151","author":"Aoki-Ota","year":"2004","journal-title":"Br. J. Dermatol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/s41584-018-0039-z","article-title":"The Role of Neutrophil Extracellular Traps in Rheumatic Diseases","volume":"14","author":"Apel","year":"2018","journal-title":"Nat. Rev. Rheumatol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.jdermsci.2008.09.008","article-title":"Lesional Th17 Cells in Pemphigus Vulgaris and Pemphigus Foliaceus","volume":"53","author":"Arakawa","year":"2009","journal-title":"J. Dermatol. Sci."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.imbio.2015.06.008","article-title":"Distinctive Treg Associated CCR4-CCL22 Expression Profile with Altered Frequency of Th17\/Treg Cell in the Immunopathogenesis of Pemphigus Vulgaris","volume":"220","author":"Asothai","year":"2015","journal-title":"Immunobiology"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1111\/bjd.19679","article-title":"ST18 Affects Cell-Cell Adhesion in Pemphigus Vulgaris in a Tumour Necrosis Factor\u2010\u03b1\u2010dependent Fashion*","volume":"184","author":"Assaf","year":"2021","journal-title":"Br. J. Dermatol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.jaad.2015.04.038","article-title":"The Role of Adjuvant Therapy in Pemphigus: A Systematic Review and Meta-Analysis","volume":"73","author":"Atzmony","year":"2015","journal-title":"J. Am. Acad. Dermatol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/cei.13495","article-title":"COVID-19 Vaccine-Readiness for Anti-CD20-depleting Therapy in Autoimmune Diseases","volume":"202","author":"Baker","year":"2020","journal-title":"Clin. Exp. Immunol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1146\/annurev-immunol-042718-041728","article-title":"The Myeloid Cell Compartment-Cell by Cell","volume":"37","author":"Bassler","year":"2019","journal-title":"Annu. Rev. Immunol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1111\/1523-1747.ep12612836","article-title":"Comparative Epidemiology of Pemphigus in Tunisia and France: Unusual Incidence of Pemphigus Foliaceus in Young Tunisian Women","volume":"104","author":"Bastuji-Garin","year":"1995","journal-title":"J. Invest. Dermatol."},{"key":"B34","first-page":"337","article-title":"Comparative Epidemiology of Pemphigus in Tunisia and France. Incidence of Foliaceus Pemphigus in Young Tunisian Women","volume":"123","author":"Bastuji-Garin","year":"1996","journal-title":"Ann. Dermatol. Venereol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1111\/j.1365-2133.2011.10732.x","article-title":"Combined Treatment with Immunoadsorption and Rituximab Leads to Fast and Prolonged Clinical Remission in Difficult-To-Treat Pemphigus Vulgaris","volume":"166","author":"Behzad","year":"2012","journal-title":"Br. J. Dermatol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2009\/187864","article-title":"Detection of Autoantibodies against Recombinant Desmoglein 1 and 3 Molecules in Patients with Pemphigus Vulgaris: Correlation with Disease Extent at the Time of Diagnosis and during Follow-Up","volume":"2009","author":"Belloni-Fortina","year":"20092009","journal-title":"Clin. Develop. Immunol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"23778","DOI":"10.1074\/jbc.M501365200","article-title":"Desmosome Signaling","volume":"280","author":"Berkowitz","year":"2005","journal-title":"J. Biol. Chem."},{"key":"B38","doi-asserted-by":"publisher","first-page":"12855","DOI":"10.1073\/pnas.0602973103","article-title":"p38MAPK Inhibition Prevents Disease in Pemphigus Vulgaris Mice","volume":"103","author":"Berkowitz","year":"2006","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B39","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1038\/sj.jid.5701080","article-title":"Induction of p38MAPK and HSP27 Phosphorylation in Pemphigus Patient Skin","volume":"128","author":"Berkowitz","year":"2008","journal-title":"J. Invest. Dermatol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1080\/08916930400027078","article-title":"Pemphigus Following Hepatitis B Vaccination-Coincidence or Causality?","volume":"38","author":"Berkun","year":"2005","journal-title":"Autoimmunity"},{"key":"B41","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1080\/08916930290016655","article-title":"Production of Non-pathogenic Human Monoclonal Antibodies to Desmoglein 3 from Pemphigus Vulgaris Patient","volume":"35","author":"Bhol","year":"2002","journal-title":"Autoimmunity"},{"key":"B42","doi-asserted-by":"publisher","first-page":"eaax9586","DOI":"10.1126\/sciadv.aax9586","article-title":"Blocking FcRn in Humans Reduces Circulating IgG Levels and Inhibits IgG Immune Complex-Mediated Immune Responses","volume":"5","author":"Blumberg","year":"2019","journal-title":"Sci. Adv."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1038\/jid.2012.1","article-title":"Differential IgG Recognition of Desmoglein 3 by Paraneoplastic Pemphigus and Pemphigus Vulgaris Sera","volume":"132","author":"Brandt","year":"2012","journal-title":"J. Invest. Dermatol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/s0738-081x(01)00254-1","article-title":"Pemphigus and Infections","volume":"20","author":"Brenner","year":"2002","journal-title":"Clin. Dermatol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jaut.2016.04.007","article-title":"Differential HLA Class I and Class II Associations in Pemphigus Foliaceus and Pemphigus Vulgaris Patients from a Prevalent Southeastern Brazilian Region","volume":"72","author":"Brochado","year":"2016","journal-title":"J. Autoimmun."},{"key":"B46","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0140-6736(05)66829-8","article-title":"Pemphigus","volume":"366","author":"Bystryn","year":"2005","journal-title":"The Lancet"},{"key":"B47","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1001\/archderm.1996.03890260105016","article-title":"The Adjuvant Therapy of Pemphigus","volume":"132","author":"Bystryn","year":"1996","journal-title":"Arch. Dermatol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.3389\/fimmu.2019.01746","article-title":"Role of Regulatory Immune Cells and Molecules in Autoimmune Bullous Dermatoses","volume":"10","author":"Cao","year":"2019","journal-title":"Front. Immunol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/j.1365-2133.2005.06882.x","article-title":"Evidence of an Association between Desmoglein 3 Haplotypes and Pemphigus Vulgaris","volume":"154","author":"Capon","year":"2006","journal-title":"Br. J. Dermatol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1111\/j.1399-0039.1996.tb02689.x","article-title":"HLA Haplotypes and Class II Molecular Alleles in Sardinian and Italian Patients with Pemphigus Vulgaris","volume":"48","author":"Carcassi","year":"1996","journal-title":"Tissue Antigens"},{"key":"B51","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1111\/ajd.12154","article-title":"Cutaneous Pemphigus Vulgaris with Absence of Desmoglein 1 Autoantibodies. An Example of the Extended Desmoglein Compensation Theory","volume":"55","author":"Carew","year":"2014","journal-title":"Australas. J. Dermatol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1590\/1984-0462\/;2019;37;1;00004","article-title":"P\u00eanfigo Neonatal Em Filho De M\u00e3e Com P\u00eanfigo Vulgar: Relato De Caso","volume":"37","author":"Carvalho","year":"2019","journal-title":"Rev. Paul. Pediatr."},{"key":"B53","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.clml.2012.11.011","article-title":"Incidence of Hypogammaglobulinemia in Patients Receiving Rituximab and the Use of Intravenous Immunoglobulin for Recurrent Infections","volume":"13","author":"Casulo","year":"2013","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1111\/j.1365-2133.2010.09696.x","article-title":"Immune Response towards the Amino-Terminus of Desmoglein 1 Prevails across Different Activity Stages in Nonendemic Pemphigus Foliaceus","volume":"162","author":"Chan","year":"2010","journal-title":"Br. J. Dermatol."},{"key":"B55","volume-title":"Skin Disease: Diagnosis and Treatment","author":"Chapman","year":"2018"},{"key":"B56","doi-asserted-by":"publisher","first-page":"2844","DOI":"10.1242\/jcs.031518","article-title":"Loss of Desmocollin 3 in Mice Leads to Epidermal Blistering","volume":"121","author":"Chen","year":"2008","journal-title":"J. Cel. Sci."},{"key":"B57","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.intimp.2015.04.046","article-title":"Pemphigus Vulgaris Antibodies Target the Mitochondrial Nicotinic Acetylcholine Receptors that Protect Keratinocytes from Apoptolysis","volume":"29","author":"Chernyavsky","year":"2015","journal-title":"Int. Immunopharmacology"},{"key":"B58","doi-asserted-by":"publisher","first-page":"4520","DOI":"10.1074\/jbc.RA118.006743","article-title":"Synergy Among Non-desmoglein Antibodies Contributes to the Immunopathology of Desmoglein Antibody-Negative Pemphigus Vulgaris","volume":"294","author":"Chernyavsky","year":"2019","journal-title":"J. Biol. Chem."},{"key":"B59","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.celrep.2019.06.066","article-title":"Single-Cell Analysis Suggests that Ongoing Affinity Maturation Drives the Emergence of Pemphigus Vulgaris Autoimmune Disease","volume":"28","author":"Cho","year":"2019","journal-title":"Cel Rep."},{"key":"B60","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.yexcr.2009.10.005","article-title":"Induction of Hyper-Adhesion Attenuates Autoimmune-Induced Keratinocyte Cell-Cell Detachment and Processing of Adhesion Molecules via Mechanisms that Involve PKC","volume":"316","author":"Cirillo","year":"2010","journal-title":"Exp. Cel Res."},{"key":"B61","doi-asserted-by":"publisher","first-page":"175ra30","DOI":"10.1126\/scitranslmed.3005166","article-title":"Long-Term Remissions of Severe Pemphigus after Rituximab Therapy Are Associated with Prolonged Failure of Desmoglein B Cell Response","volume":"5","author":"Colliou","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"B62","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1111\/ijd.14395","article-title":"Clinical, Pathologic, and Immunologic Features of Pemphigus Herpetiformis: a Literature Review and Proposed Diagnostic Criteria","volume":"58","author":"Costa","year":"2019","journal-title":"Int. J. Dermatol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1046\/j.1365-2133.2002.47958.x","article-title":"Pemphigus Following Tetanus and Diphtheria Vaccination","volume":"147","author":"Cozzani","year":"2002","journal-title":"Br. J. Dermatol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1684\/ejd.2007.0270","article-title":"Pemphigus Vegetans Neumann Type with Anti-desmoglein and Anti-periplakin Autoantibodies","volume":"17","author":"Cozzani","year":"2007","journal-title":"Eur. J. Dermatol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nrrheum.2012.58","article-title":"Follicular Helper T Cells in Immunity and Systemic Autoimmunity","volume":"8","author":"Craft","year":"2012","journal-title":"Nat. Rev. Rheumatol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1001\/archderm.134.11.1486","article-title":"Stressful Life Events as Potential Triggers of Pemphigus","volume":"134","author":"Cremniter","year":"1998","journal-title":"Arch. Dermatol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"13030\/qt91q8q1f1","DOI":"10.5070\/d32610050470","article-title":"Hallopeau Type of Pemphigus Vegetans, an Unusual Clinical Presentation of an Infrequent Disease","volume":"26","author":"Cuellar","year":"2020","journal-title":"Dermatol. Online J."},{"key":"B68","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.jaut.2008.08.003","article-title":"Advances in Pemphigus and its Endemic Pemphigus Foliaceus (Fogo Selvagem) Phenotype: a Paradigm of Human Autoimmunity","volume":"31","author":"Culton","year":"2008","journal-title":"J. Autoimmun."},{"key":"B69","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.humimm.2010.04.001","article-title":"Polymorphisms in the 2q33 and 3q21 Chromosome Regions Including T-Cell Coreceptor and Ligand Genes May Influence Susceptibility to Pemphigus Foliaceus","volume":"71","author":"Dalla-Costa","year":"2010","journal-title":"Hum. Immunol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"e645","DOI":"10.1111\/jdv.17472","article-title":"The First Dose of COVID\u201019 Vaccine May Trigger Pemphigus and Bullous Pemphigoid Flares: Is the Second Dose Therefore Contraindicated?","volume":"35","author":"Damiani","year":"2021","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1111\/j.1468-3083.2007.02254.x","article-title":"Desmoglein 1 and 3 Enzyme-Linked Immunosorbent Assay in Iranian Patients with Pemphigus Vulgaris: Correlation with Phenotype, Severity, and Disease Activity","volume":"21","author":"Daneshpazhooh","year":"2007","journal-title":"J. Eur. Acad. Dermatol. Venerol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1111\/ddg.12738","article-title":"Trauma-induced Pemphigus: a Case Series of 36 Patients","volume":"14","author":"Daneshpazhooh","year":"2016","journal-title":"JDDG: J. der Deutschen Dermatologischen Gesellschaft"},{"key":"B73","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3109\/08916934.2015.1134512","article-title":"Tumor Necrosis Factor (TNF)-\u03b1\u2212308G\/A (Rs1800629) Polymorphism Distribution in North India and its Association with Pemphigus: Case-Control Study and Meta-Analysis","volume":"49","author":"Dar","year":"2016","journal-title":"Autoimmunity"},{"key":"B74","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s12026-020-09166-0","article-title":"Distorted Frequency of Dendritic Cells and Their Associated Stimulatory and Inhibitory Markers Augment the Pathogenesis of Pemphigus Vulgaris","volume":"68","author":"Das","year":"2020","journal-title":"Immunol. Res."},{"key":"B75","doi-asserted-by":"publisher","first-page":"e272","DOI":"10.1016\/S2352-3026(17)30078-9","article-title":"Efficacy and Safety of Subcutaneous Rituximab versus Intravenous Rituximab for First-Line Treatment of Follicular Lymphoma (SABRINA): a Randomised, Open-Label, Phase 3 Trial","volume":"4","author":"Davies","year":"2017","journal-title":"Lancet Haematol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.yexmp.2019.03.009","article-title":"High-resolution Melting Analysis to Screen the ST18 Gene Functional Risk Variant for Pemphigus Vulgaris: The Occasion to Open a Debate on its Usefulness in Clinical Setting","volume":"108","author":"De Bonis","year":"2019","journal-title":"Exp. Mol. Pathol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1111\/bjd.17136","article-title":"Fingernail Involvement in Pemphigus and its Correlation with Disease Severity and Other Clinicodemographic Parameters","volume":"180","author":"De","year":"2019","journal-title":"Br. J. Dermatol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1111\/j.1365-2230.2008.02835.x","article-title":"Exacerbation of Pemphigus after Influenza Vaccination","volume":"33","author":"De Simone","year":"2008","journal-title":"Clin. Exp. Dermatol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1126\/science.aan8423","article-title":"DNGR-1 in Dendritic Cells Limits Tissue Damage by Dampening Neutrophil Recruitment","volume":"362","author":"Del Fresno","year":"2018","journal-title":"Science"},{"key":"B80","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1111\/j.1399-0039.1996.tb02690.x","article-title":"MHC Class II Alleles and Haplotypes in Patients with Pemphigus Vulgaris from India","volume":"48","author":"Delgado","year":"1996","journal-title":"Tissue Antigens"},{"key":"B81","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3389\/fimmu.2017.00081","article-title":"Neutrophil Extracellular Traps and its Implications in Inflammation: An Overview","volume":"8","author":"Delgado-Rizo","year":"2017","journal-title":"Front. Immunol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/gene.2013.44","article-title":"Genome-wide Expression Analysis Suggests Unique Disease-Promoting and Disease-Preventing Signatures in Pemphigus Vulgaris","volume":"14","author":"Dey-Rao","year":"2013","journal-title":"Genes Immun."},{"key":"B83","doi-asserted-by":"publisher","first-page":"3781","DOI":"10.1172\/JCI64413","article-title":"Pemphigus Autoantibodies Generated through Somatic Mutations Target the Desmoglein-3 Cis-Interface","volume":"122","author":"Di Zenzo","year":"2012","journal-title":"J. Clin. Invest."},{"key":"B84","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/1523-1747.ep13070394","article-title":"Endemic Pemphigus Foliaceus (Fogo Selvagem): II. Current and Historic Epidemiologic Studies","volume":"92","author":"Diaz","year":"1989","journal-title":"J. Invest. Dermatol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.3389\/fimmu.2019.01418","article-title":"Pemphigus: Current and Future Therapeutic Strategies","volume":"10","author":"Didona","year":"2019","journal-title":"Front. Immunol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/bf00372587","article-title":"The Analysis of IgG Subclasses of Anti-intercellular Antibodies in Pemphigus by an Immunoblot Technique","volume":"284","author":"Dmochowski","year":"1992","journal-title":"Arch. Dermatol. Res."},{"key":"B87","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1111\/1523-1747.ep12471934","article-title":"Desmocollins I and II Are Recognized by Certain Sera from Patients with Various Types of Pemphigus, Particularly Brazilian Pemphigues Foliaceus","volume":"100","author":"Dmochowski","year":"1993","journal-title":"J. Invest. Dermatol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/s41590-019-0420-3","article-title":"Plasmacytoid Dendritic Cells Develop from Ly6D+ Lymphoid Progenitors Distinct from the Myeloid Lineage","volume":"20","author":"Dress","year":"2019","journal-title":"Nat. Immunol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s00403-004-0528-6","article-title":"Cytokine Polymorphisms in Patients with Pemphigus","volume":"296","author":"Eberhard","year":"2005","journal-title":"Arch. Dermatol. Res."},{"key":"B90","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1001\/jamadermatol.2014.1939","article-title":"Subcutaneous Veltuzumab, a Humanized Anti-CD20 Antibody, in the Treatment of Refractory Pemphigus Vulgaris","volume":"150","author":"Ellebrecht","year":"2014","journal-title":"JAMA Dermatol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1126\/science.aaf6756","article-title":"Reengineering Chimeric Antigen Receptor T Cells for Targeted Therapy of Autoimmune Disease","volume":"353","author":"Ellebrecht","year":"2016","journal-title":"Science"},{"key":"B92","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1080\/08916930600972040","article-title":"Immunoadsorption in Pemphigus","volume":"39","author":"Eming","year":"2006","journal-title":"Autoimmunity"},{"key":"B93","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1046\/j.1365-2133.2000.03901.x","article-title":"Frequency Analysis of Autoreactive T\u2010helper 1 and 2 Cells in Bullous Pemphigoid and Pemphigus Vulgaris by Enzyme\u2010linked Immunospot Assay","volume":"143","author":"Eming","year":"2000","journal-title":"Br. J. Dermatol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"4391","DOI":"10.4049\/jimmunol.1401081","article-title":"Pathogenic IgG Antibodies against Desmoglein 3 in Pemphigus Vulgaris Are Regulated by HLA-Drb1*04:02-Restricted T Cells","volume":"193","author":"Eming","year":"2014","journal-title":"J.I."},{"key":"B95","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1111\/exd.13778","article-title":"The Association between ST 18 Gene Polymorphism and Severe Pemphigus Disease Among Iranian Population","volume":"27","author":"Etesami","year":"2018","journal-title":"Exp. Dermatol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1038\/sj.jid.5701260","article-title":"E-cadherin Is an Additional Immunological Target for Pemphigus Autoantibodies","volume":"128","author":"Evangelista","year":"2008","journal-title":"J. Invest. Dermatol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1084\/jem.165.6.1719","article-title":"Human Autoantibodies against a Desmosomal Protein Complex with a Calcium-Sensitive Epitope Are Characteristic of Pemphigus Foliaceus Patients","volume":"165","author":"Eyre","year":"1987","journal-title":"J. Exp. Med."},{"key":"B98","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1172\/JCI113387","article-title":"Identification of Pemphigus Vulgaris Antigen Extracted from normal Human Epidermis and Comparison with Pemphigus Foliaceus Antigen","volume":"81","author":"Eyre","year":"1988","journal-title":"J. Clin. Invest."},{"key":"B99","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/pde.14059","article-title":"A Case of Neonatal Pemphigus Vulgaris with Co\u2010existing BP180 Autoantibodies","volume":"37","author":"Fenner","year":"2020","journal-title":"Pediatr. Dermatol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1111\/j.1525-1470.2006.00195.x","article-title":"Neonatal Pemphigus Vulgaris in an Infant Born to a Mother with Pemphigus Vulgaris in Remission","volume":"23","author":"Fenniche","year":"2006","journal-title":"Pediatr. Dermatol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1172\/JCI511","article-title":"Anti-FcepsilonRIalpha Autoantibodies in Autoimmune-Mediated Disorders. Identification of a Structure-Function Relationship","volume":"101","author":"Fiebiger","year":"1998","journal-title":"J. Clin. Invest."},{"key":"B102","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s11926-007-0075-1","article-title":"Pathophysiology of Psoriasis: Recent Advances on IL-23 and Th17 Cytokines","volume":"9","author":"Fitch","year":"2007","journal-title":"Curr. Rheumatol. Rep."},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2077","article-title":"Progressive Multifocal Leukoencephalopathy and anti\u2010CD20 Monoclonal Antibodies: What Do We Know after 20 Years of Rituximab","volume":"29","author":"Focosi","year":"2019","journal-title":"Rev. Med. Virol."},{"key":"B104","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1001\/jamadermatol.2020.3990","article-title":"Neonatal Pemphigus Vulgaris","volume":"157","author":"Foster","year":"2021","journal-title":"JAMA Dermatol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1196\/annals.1313.040","article-title":"The Interaction of Pemphigus Autoimmunoglobulins with Epidermal Cells: Activation of the Fas Apoptotic Pathway and the Use of Caspase Activity for Pathogenicity Tests of Pemphigus Patients","volume":"1050","author":"Fru\u0161i\u0107-zlotkin","year":"2005","journal-title":"Ann. N.Y Acad. Sci."},{"key":"B106","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/S0190-9622(09)80116-3","article-title":"Pemphigus Vulgaris after Initiation of Psoralen and UVA Therapy for Psoriasis","volume":"30","author":"Fryer","year":"1994","journal-title":"J. Am. Acad. Dermatol."},{"key":"B107","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1046\/j.1523-1747.2000.00137.x","article-title":"Use of Domain-Swapped Molecules for Conformational Epitope Mapping of Desmoglein 3 in Pemphigus Vulgaris","volume":"115","author":"Futei","year":"2000","journal-title":"J. Invest. Dermatol."},{"key":"B108","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/nri2506","article-title":"Myeloid-derived Suppressor Cells as Regulators of the Immune System","volume":"9","author":"Gabrilovich","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"B109","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/747506","article-title":"Conservative Approach in Patients with Pemphigus Gingival Vulgaris: A Pilot Study of Five Cases","volume":"2014","author":"Gambino","year":"20142014","journal-title":"Int. J. Dentistry"},{"key":"B110","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1111\/exd.12299","article-title":"Lack of Expression of an Alternative CD20 Transcript Variant in Circulating B Cells from Patients with Pemphigus","volume":"23","author":"Gamonet","year":"2014","journal-title":"Exp. Dermatol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1016\/j.jid.2018.05.011","article-title":"Association Study and Fine-Mapping Major Histocompatibility Complex Analysis of Pemphigus Vulgaris in a Han Chinese Population","volume":"138","author":"Gao","year":"2018","journal-title":"J. Invest. Dermatol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.autrev.2004.05.002","article-title":"The Immunogenetics of Pemphigus Vulgaris","volume":"4","author":"Gazit","year":"2005","journal-title":"Autoimmun. Rev."},{"key":"B113","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1111\/bjd.12940","article-title":"The Expanding Spectrum ofIgApemphigus: a Case Report and Review of the Literature","volume":"171","author":"Geller","year":"2014","journal-title":"Br. J. Dermatol."},{"key":"B114","first-page":"166","article-title":"Association between Pemphigus Vulgaris and Human Leukocyte Antigen in Han Nation of Northeast China","volume":"20","author":"Geng","year":"2005","journal-title":"Chin. Med. Sci. J."},{"key":"B115","doi-asserted-by":"publisher","first-page":"107299","DOI":"10.1016\/j.intimp.2020.107299","article-title":"Drug-induced Pemphigus: A Systematic Review of 170 Patients","volume":"92","author":"Ghaedi","year":"2021","journal-title":"Int. Immunopharmacology"},{"key":"B116","doi-asserted-by":"publisher","first-page":"20782","DOI":"10.1111\/bjd.20782","article-title":"Treatment of Pemphigus Vulgaris and Foliaceus with Efgartigimod, a Neonatal Fc Receptor Inhibitor: a Phase II Multicentre, Open\u2010label Feasibility Trial","author":"Goebeler","year":"2021","journal-title":"Br. J. Dermatol."},{"key":"B117","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1111\/j.1365-2133.2007.07800.x","article-title":"Rituximab in the Adjuvant Treatment of Pemphigus Vulgaris: a Prospective Open-Label Pilot Study in Five Patients","volume":"156","author":"Goh","year":"2007","journal-title":"Br. J. Dermatol."},{"key":"B118","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1590\/s0365-05962011000600007","article-title":"Incidence of Pemphigus Vulgaris Exceeds that of Pemphigus Foliaceus in a Region where Pemphigus Foliaceus Is Endemic: Analysis of a 21-year Historical Series","volume":"86","author":"Gon\u00e7alves","year":"2011","journal-title":"Bras Dermatol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/S0190-9622(98)70476-1","article-title":"Use of Topical Cyclosporin in Oral Pemphigus","volume":"38","author":"Gooptu","year":"1998","journal-title":"J. Am. Acad. Dermatol."},{"key":"B120","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1001\/archderm.136.10.1269","article-title":"Nicotine and Pemphigus","volume":"136","author":"Grando","year":"2000","journal-title":"Arch. Dermatol."},{"key":"B121","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1159\/000051540","article-title":"Autoimmunity to Keratinocyte Acetylcholine Receptors in Pemphigus","volume":"201","author":"Grando","year":"2000","journal-title":"Dermatology"},{"key":"B122","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1111\/ijd.14143","article-title":"Retrospective Analysis of a Single\u2010center Clinical Experience toward Development of Curative Treatment of 123 Pemphigus Patients with a Long\u2010term Follow\u2010up: Efficacy and Safety of the Multidrug Protocol Combining Intravenous Immunoglobulin with the Cytotoxic Immunosuppressor and Mitochondrion\u2010protecting Drugs","volume":"58","author":"Grando","year":"2019","journal-title":"Int. J. Dermatol."},{"key":"B123","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1001\/archdermatol.2008.503","article-title":"Effect of Intravenous Immunoglobulin Therapy on Serum Levels of IgG1 and IgG4 Antidesmoglein 1 and Antidesmoglein 3 Antibodies in Pemphigus Vulgaris","volume":"144","author":"Green","year":"2008","journal-title":"Arch. Dermatol."},{"key":"B124","first-page":"9","article-title":"Rituximab: an Insider\u2019s Historical Perspective","volume":"27","author":"Grillo-L\u00f3pez","year":"2000","journal-title":"Semin. Oncol."},{"key":"B125","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1111\/j.1365-2133.2009.09246.x","article-title":"Analysis of Current Data on the Use of Methotrexate in the Treatment of Pemphigus and Pemphigoid","volume":"161","author":"G\u00fcrcan","year":"2009","journal-title":"Br. J. Dermatol."},{"key":"B126","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1111\/j.1346-8138.2008.00515.x","article-title":"Neonatal Pemphigus Vulgaris","volume":"35","author":"Gushi","year":"2008","journal-title":"J. Dermatol."},{"key":"B127","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1080\/09546634.2018.1484873","article-title":"Rituximab\/IVIG in Pemphigus - a 10-year Study with a Long Follow-Up","volume":"30","author":"Hamadah","year":"2019","journal-title":"J. Dermatol. Treat."},{"key":"B128","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1146\/annurev-pathol-012615-044313","article-title":"Mechanisms of Disease: Pemphigus and Bullous Pemphigoid","volume":"11","author":"Hammers","year":"2016","journal-title":"Annu. Rev. Pathol. Mech. Dis."},{"key":"B129","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1038\/jid.2014.291","article-title":"Persistence of Anti-desmoglein 3 IgG + B-Cell Clones in Pemphigus Patients over Years","volume":"135","author":"Hammers","year":"2015","journal-title":"J. Invest. Dermatol."},{"key":"B130","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1111\/bjd.15930","article-title":"British Association of Dermatologists' Guidelines for the Management of Pemphigus Vulgaris 2017","volume":"177","author":"Harman","year":"2017","journal-title":"Br. J. Dermatol."},{"key":"B131","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1001\/archderm.1977.01640110038003","article-title":"HLA-A10 in Pemphigus Among Japanese","volume":"113","author":"Hashimoto","year":"1977","journal-title":"Arch. Dermatol."},{"key":"B132","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/j.1365-2230.1983.tb01742.x","article-title":"Atypical Pemphigus Showing Eosinophilic Spongiosis","volume":"8","author":"Hashimoto","year":"1983","journal-title":"Clin. Exp. Dermatol."},{"key":"B133","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1001\/archderm.1984.01650420072019","article-title":"Penicillamine-Induced Pemphigus","volume":"120","author":"Hashimoto","year":"1984","journal-title":"Arch. Dermatol."},{"key":"B134","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1111\/1523-1747.ep12277087","article-title":"Characterization of Keratinocyte Plasminogen Activator Inhibitors and Demonstration of the Prevention of Pemphigus IgG-Induced Acantholysis by a Purified Plasminogen Activator Inhibitor","volume":"92","author":"Hashimoto","year":"1989","journal-title":"J. Invest. Dermatol."},{"key":"B135","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/1523-1747.ep12874456","article-title":"Detection of Pemphigus Vulgaris and Pemphigus Foliaceus Antigens by Immunoblot Analysis Using Different Antigen Sources","volume":"94","author":"Hashimoto","year":"1990","journal-title":"J. Invest. Dermatol."},{"key":"B136","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/0923-1811(94)90083-3","article-title":"Detection of Anti-desmocollins I and II Autoantibodies in Two Cases of Hallopeau Type Pemphigus Vegetans by Immunoblot Analysis","volume":"7","author":"Hashimoto","year":"1994","journal-title":"J. Dermatol. Sci."},{"key":"B137","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1111\/1523-1747.ep12607012","article-title":"Characterization of Paraneoplastic Pemphigus Autoantigens by Immunoblot Analysis","volume":"104","author":"Hashimoto","year":"1995","journal-title":"J. Invest. Dermatol."},{"key":"B138","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/1523-1747.ep12319025","article-title":"Human Desmocollin 1 (Dsc1) Is an Autoantigen for the Subcorneal Pustular Dermatosis Type of IgA Pemphigus","volume":"109","author":"Hashimoto","year":"1997","journal-title":"J. Invest. Dermatol."},{"key":"B139","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.3389\/fimmu.2019.01794","article-title":"Modifications of the Transcriptomic Profile of Autoreactive B Cells from Pemphigus Patients after Treatment with Rituximab or a Standard Corticosteroid Regimen","volume":"10","author":"H\u00e9bert","year":"2019","journal-title":"Front. Immunol."},{"key":"B140","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/bjd.18563","article-title":"Comparison of Real Costs in the French Healthcare System in Newly Diagnosed Patients with Pemphigus for First\u2010line Treatment with Rituximab vs. Standard Corticosteroid Regimen: Data from a National Multicentre Trial","volume":"183","author":"H\u00e9bert","year":"2020","journal-title":"Br. J. Dermatol."},{"key":"B141","doi-asserted-by":"publisher","first-page":"666022","DOI":"10.3389\/fimmu.2021.666022","article-title":"Modifications of the BAFF\/BAFF-Receptor Axis in Patients with Pemphigus Treated with Rituximab versus Standard Corticosteroid Regimen","volume":"12","author":"H\u00e9bert","year":"2021","journal-title":"Front. Immunol."},{"key":"B142","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1002\/1096-8652(200102)66:2<142::AID-AJH1032>3.0.CO;2-0","article-title":"Successful Treatment of Paraneoplastic Pemphigus in Follicular NHL with Rituximab: Report of a Case and Review of Treatment for Paraneoplastic Pemphigus in NHL and CLL","volume":"66","author":"Heizmann","year":"2001","journal-title":"Am. J. Hematol."},{"key":"B143","doi-asserted-by":"publisher","first-page":"e0148919","DOI":"10.1371\/journal.pone.0148919","article-title":"Increased Frequency of T Follicular Helper Cells and Elevated Interleukin-27 Plasma Levels in Patients with Pemphigus","volume":"11","author":"Hennerici","year":"2016","journal-title":"PLoS ONE"},{"key":"B144","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/jdv.12772","article-title":"Pemphigus. S2 Guideline for Diagnosis and Treatment - Guided by the European Dermatology Forum (EDF) in Cooperation with the European Academy of Dermatology and Venereology (EADV)","volume":"29","author":"Hertl","year":"2015","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"B145","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.4049\/jimmunol.181.3.1825","article-title":"Pemphigus Vulgaris IgG Directly Inhibit Desmoglein 3-mediated Transinteraction","volume":"181","author":"Heupel","year":"2008","journal-title":"J. Immunol."},{"key":"B146","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/s41577-019-0162-3","article-title":"T Cells and the Skin: from Protective Immunity to Inflammatory Skin Disorders","volume":"19","author":"Ho","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"B147","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1111\/cup.13992","article-title":"Pemphigus Erythematosus: A Case Series from a Tertiary Academic center and Literature Review","volume":"48","author":"Hobbs","year":"2021","journal-title":"J. Cutan. Pathol."},{"key":"B148","first-page":"142","article-title":"Topical Tacrolimus: a Novel Therapeutic Intervention for Recalcitrant Labial Pemphigus Vulgaris","volume":"13","author":"Hodgson","year":"2003","journal-title":"Eur. J. Dermatol."},{"key":"B149","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.1016\/j.jaci.2020.11.008","article-title":"Immunophenotyping in Pemphigus Reveals a TH17\/TFH17 Cell-Dominated Immune Response Promoting Desmoglein1\/3-specific Autoantibody Production","volume":"147","author":"Holstein","year":"2021","journal-title":"J. Allergy Clin. Immunol."},{"key":"B150","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/j.1600-065X.1999.tb01319.x","article-title":"Viruses, Host Responses, and Autoimmunity","volume":"169","author":"Horwitz","year":"1999","journal-title":"Immunol. Rev."},{"key":"B151","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/S1474-4422(21)00159-9","article-title":"Safety, Efficacy, and Tolerability of Efgartigimod in Patients with Generalised Myasthenia Gravis (ADAPT): a Multicentre, Randomised, Placebo-Controlled, Phase 3 Trial","volume":"20","author":"Howard","year":"2021","journal-title":"Lancet Neurol."},{"key":"B152","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1111\/bjd.14463","article-title":"Comorbidities and Inpatient Mortality for Pemphigus in the U.S.A","volume":"174","author":"Hsu","year":"2016","journal-title":"Br. J. Dermatol."},{"key":"B153","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1097\/00042728-200502000-00023","article-title":"Pemphigus Vegetans Occurring in a Split-Thickness Skin Graft","volume":"31","author":"Huang","year":"2005","journal-title":"Dermatol. Surg."},{"key":"B154","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1016\/j.jid.2016.07.013","article-title":"Prevalence and Age Distribution of Pemphigus and Pemphigoid Diseases in Germany","volume":"136","author":"H\u00fcbner","year":"2016","journal-title":"J. Invest. Dermatol."},{"key":"B155","doi-asserted-by":"publisher","first-page":"210","DOI":"10.4103\/0019-5154.127712","article-title":"Localized Pemphigus Vegetans without Mucosal Involvement","volume":"59","author":"Imchen","year":"2014","journal-title":"Indian J. Dermatol."},{"key":"B156","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1046\/j.1365-2133.2001.04095.x","article-title":"Paraneoplastic Pemphigus without Antidesmoglein 3 or Antidesmoglein 1 Autoantibodies","volume":"144","author":"Inaoki","year":"2001","journal-title":"Br. J. Dermatol."},{"key":"B157","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1046\/j.1365-2133.2001.04031.x","article-title":"Immunoblotting Detection of Gamma-Catenin (Plakoglobin) Antibody in the Serum of a Patient with Paraneoplastic Pemphigus","volume":"144","author":"Ishii","year":"2001","journal-title":"Br. J. Dermatol."},{"key":"B158","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1038\/sj.jid.5701132","article-title":"Isolation of Pathogenic Monoclonal Anti-desmoglein 1 Human Antibodies by Phage Display of Pemphigus Foliaceus Autoantibodies","volume":"128","author":"Ishii","year":"2008","journal-title":"J. Invest. Dermatol."},{"key":"B159","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/bjd.13711","article-title":"Anti-desmocollin Autoantibodies in Nonclassical Pemphigus","volume":"173","author":"Ishii","year":"2015","journal-title":"Br. J. Dermatol."},{"key":"B160","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1111\/j.1365-4362.1975.tb00125.x","article-title":"Herpetiform Pemphigus, a Variable Pattern of Pemphigus","volume":"14","author":"Jablonska","year":"1975","journal-title":"Int. J. Dermatol."},{"key":"B161","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1111\/j.1365-4362.1989.tb01365.x","article-title":"Pemphigus Vegetans in an Unusual Site","volume":"28","author":"Jain","year":"1989","journal-title":"Int. J. Dermatol."},{"key":"B162","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1016\/j.immuni.2019.03.001","article-title":"A Subset of Type I Conventional Dendritic Cells Controls Cutaneous Bacterial Infections through VEGF\u03b1-Mediated Recruitment of Neutrophils","volume":"50","author":"Janela","year":"2019","journal-title":"Immunity"},{"key":"B163","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.jid.2018.07.042","article-title":"Incidence and Mortality of Pemphigus in France","volume":"139","author":"Jelti","year":"2019","journal-title":"J. Invest. Dermatol."},{"key":"B164","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/jid.2010.389","article-title":"Desmosome Disassembly in Response to Pemphigus Vulgaris IgG Occurs in Distinct Phases and Can Be Reversed by Expression of Exogenous Dsg3","volume":"131","author":"Jennings","year":"2011","journal-title":"J. Invest. Dermatol."},{"key":"B165","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/8206983","article-title":"Involvement of the IL23\/Th17 Pathway in the Pathogenesis of Tunisian Pemphigus Foliaceus","volume":"2018","author":"Jmaa","year":"20182018","journal-title":"Mediators Inflamm."},{"key":"B166","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1046\/j.1365-2230.2001.00779.x","article-title":"A Review of High-Dose Intravenous Immunoglobulin (hdIVIg) in the Treatment of the Autoimmune Blistering Disorders","volume":"26","author":"Jolles","year":"2001","journal-title":"Clin. Exp. Dermatol."},{"key":"B167","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.clindermatol.2011.01.013","article-title":"Pemphigus Group (Vulgaris, Vegetans, Foliaceus, Herpetiformis, Brasiliensis)","volume":"29","author":"Joly","year":"2011","journal-title":"Clin. Dermatol."},{"key":"B168","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1067\/mjd.2000.107488","article-title":"Sensitivity and Specificity of Clinical, Histologic, and Immunologic Features in the Diagnosis of Paraneoplastic Pemphigus","volume":"43","author":"Joly","year":"2000","journal-title":"J. Am. Acad. Dermatol."},{"key":"B169","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1016\/S0140-6736(17)30070-3","article-title":"First-line Rituximab Combined with Short-Term Prednisone versus Prednisone Alone for the Treatment of Pemphigus (Ritux 3): a Prospective, Multicentre, Parallel-Group, Open-Label Randomised Trial","volume":"389","author":"Joly","year":"2017","journal-title":"The Lancet"},{"key":"B170","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1111\/jdv.16752","article-title":"Updated S2K Guidelines on the Management of Pemphigus Vulgaris and Foliaceus Initiated by the European Academy of Dermatology and Venereology (EADV)","volume":"34","author":"Joly","year":"2020","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"B171","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3389\/fimmu.2020.00433","article-title":"Systematic Review of Safety and Efficacy of Atacicept in Treating Immune-Mediated Disorders","volume":"11","author":"Kaegi","year":"2020","journal-title":"Front. Immunol."},{"key":"B172","doi-asserted-by":"publisher","first-page":"e57587","DOI":"10.1371\/journal.pone.0057587","article-title":"Pemphigus Vulgaris Autoantibody Profiling by Proteomic Technique","volume":"8","author":"Kalantari-Dehaghi","year":"2013","journal-title":"PLoS ONE"},{"key":"B173","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/j.1365-2133.2012.10929.x","article-title":"Detection of Antibodies against the Non-calcium-dependent Epitopes of Desmoglein 3 in Pemphigus Vulgaris and Their Pathogenic Significance","volume":"167","author":"Kamiya","year":"2012","journal-title":"Br. J. Dermatol."},{"key":"B174","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.jdermsci.2013.02.011","article-title":"A Higher Correlation of the Antibody Activities against the Calcium-dependent Epitopes of Desmoglein 3 Quantified by Ethylenediaminetetraacetic Acid-Treated Enzyme-Linked Immunosorbent Assay with Clinical Disease Activities of Pemphigus Vulgaris","volume":"70","author":"Kamiya","year":"2013","journal-title":"J. Dermatol. Sci."},{"key":"B175","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1111\/j.1365-4632.2012.5847.x","article-title":"Adjuvant Rituximab in the Treatment of Pemphigus Vulgaris: a Phase II Clinical Trial","volume":"52","author":"Kamran","year":"2013","journal-title":"Int. J. Dermatol."},{"key":"B176","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1159\/000018456","article-title":"Pemphigus Foliaceus Induced by Exposure to Sunlight","volume":"201","author":"Kano","year":"2000","journal-title":"Dermatology"},{"key":"B177","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1111\/j.1365-4362.1991.tb03872.x","article-title":"Pemphigus in Children","volume":"30","author":"Kanwar","year":"1991","journal-title":"Int. J. Dermatol."},{"key":"B178","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1097\/OGX.0b013e3181bea089","article-title":"Pemphigus Vulgaris in Pregnancy","volume":"64","author":"Kardos","year":"2009","journal-title":"Obstetrical Gynecol. Surv."},{"key":"B179","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1034\/j.1600-0625.2000.009003224.x","article-title":"Identification of Desmoglein 1 as Autoantigen in a Patient with Intraepidermal Neutrophilic IgA Dermatosis Type of IgA Pemphigus","volume":"9","author":"K\u00e1rp\u00e1ti","year":"2000","journal-title":"Exp. Dermatol."},{"key":"B180","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.jaad.2013.11.043","article-title":"Pemphigus Herpetiformis: From First Description until Now","volume":"70","author":"Kasperkiewicz","year":"2014","journal-title":"J. Am. Acad. Dermatol."},{"key":"B181","doi-asserted-by":"publisher","first-page":"17026","DOI":"10.1038\/nrdp.2017.26","article-title":"Pemphigus","volume":"3","author":"Kasperkiewicz","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"B182","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1080\/08916930600971943","article-title":"Pathogenic Monoclonal Antibody against Desmoglein 3 Augments Desmoglein 3 and P38 MAPK Phosphorylation in Human Squamous Carcinoma Cell Line","volume":"39","author":"Kawasaki","year":"2006","journal-title":"Autoimmunity"},{"key":"B183","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1046\/j.1523-1747.2000.00088-2.x","article-title":"Envoplakin and Periplakin, the Paraneoplastic Pemphigus Antigens, Are Also Recognized by Pemphigus Foliaceus Autoantibodies","volume":"115","author":"Kazerounian","year":"2000","journal-title":"J. Invest. Dermatol."},{"key":"B184","first-page":"105","article-title":"Pemphigus Foliaceus: a Case Report and Short Review","volume":"78","author":"Khachemoune","year":"2006","journal-title":"Cutis"},{"key":"B185","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1111\/1523-1747.ep12336235","article-title":"cDNA Cloning of the 210-kDa Paraneoplastic Pemphigus Antigen Reveals that Envoplakin Is a Component of the Antigen Complex","volume":"109","author":"Kim","year":"1997","journal-title":"J. Invest. Dermatol."},{"key":"B186","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1046\/j.1365-2133.2001.04415.x","article-title":"Pemphigus Vulgaris with Autoantibodies to Desmoplakin","volume":"145","author":"Kim","year":"2001","journal-title":"Br. J. Dermatol."},{"key":"B187","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.jaci.2020.03.036","article-title":"Targeting Inducible Costimulator Expressed on CXCR5+PD-1+ TH Cells Suppresses the Progression of Pemphigus Vulgaris","volume":"146","author":"Kim","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"key":"B188","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.ebiom.2017.12.022","article-title":"Langerhans Cells Prevent Autoimmunity via Expansion of Keratinocyte Antigen-specific Regulatory T Cells","volume":"27","author":"Kitashima","year":"2018","journal-title":"EBioMedicine"},{"key":"B189","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S0092-8674(03)00273-3","article-title":"Desmoglein 4 in Hair Follicle Differentiation and Epidermal Adhesion","volume":"113","author":"Kljuic","year":"2003","journal-title":"Cell"},{"key":"B190","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1111\/j.1610-0387.2011.07793.x","article-title":"Autoimmune Bullous Skin Diseases. Part 1: Clinical Manifestations","volume":"9","author":"Kneisel","year":"","journal-title":"JDDG: J. der Deutschen Dermatologischen Gesellschaft"},{"key":"B191","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1111\/j.1610-0387.2011.07809.x","article-title":"Autoimmune Bullous Skin Diseases. Part 2: Diagnosis and Therapy","volume":"9","author":"Kneisel","year":"","journal-title":"JDDG: J. der Deutschen Dermatologischen Gesellschaft"},{"key":"B192","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1083\/jcb.137.5.1091","article-title":"Targeted Disruption of the Pemphigus Vulgaris Antigen (Desmoglein 3) Gene in Mice Causes Loss of Keratinocyte Cell Adhesion with a Phenotype Similar to Pemphigus Vulgaris","volume":"137","author":"Koch","year":"1997","journal-title":"J. Cel Biol."},{"key":"B193","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1111\/j.1365-2133.2012.10827.x","article-title":"Five Japanese Cases of Antidesmoglein 1 Antibody\u2010positive and Antidesmoglein 3 Antibody\u2010negative Pemphigus with Oral Lesions","volume":"166","author":"Koga","year":"2012","journal-title":"Br. J. Dermatol."},{"key":"B194","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1056\/NEJM198909073211002","article-title":"Demonstration of an Adhering-Junction Molecule (Plakoglobin) in the Autoantigens of Pemphigus Foliaceus and Pemphigus Vulgaris","volume":"321","author":"Korman","year":"1989","journal-title":"N. Engl. J. Med."},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.1111\/odi.14089","article-title":"Development of Pemphigus Vulgaris after the Second Dose of the mRNA\u20101273 SARS\u2010Cov\u20102 Vaccine","author":"Koutlas","year":"2021","journal-title":"Oral Dis."},{"key":"B196","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1067\/mjd.2003.23","article-title":"Pemphigus Herpetiformis with IgA and IgG Antibodies to Desmoglein 1 and IgG Antibodies to Desmocollin 3","volume":"48","author":"Kozlowska","year":"2003","journal-title":"J. Am. Acad. Dermatol."},{"key":"B197","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.2340\/00015555-2706","article-title":"Pemphigus Vulgaris and Pemphigus Foliaceus: Differences in Epidemiology and Mortality","volume":"97","author":"Kridin","year":"2017","journal-title":"Acta Derm Venerol"},{"key":"B198","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/j.jaad.2019.11.059","article-title":"IgA Pemphigus: A Systematic Review","volume":"82","author":"Kridin","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"key":"B199","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s12026-018-8986-7","article-title":"Pemphigus Group: Overview, Epidemiology, Mortality, and Comorbidities","volume":"66","author":"Kridin","year":"2018","journal-title":"Immunol. Res."},{"key":"B200","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1001\/jamadermatol.2019.3236","article-title":"Factors Associated with Complete Remission after Rituximab Therapy for Pemphigus","volume":"155","author":"Kushner","year":"2019","journal-title":"JAMA Dermatol."},{"key":"B201","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.jaad.2016.11.039","article-title":"Correlation of Antimuscarinic Acetylcholine Receptor Antibody Titers and Antidesmoglein Antibody Titers with the Severity of Disease in Patients with Pemphigus","volume":"76","author":"Lakshmi","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"key":"B202","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1111\/j.1365-2133.2010.09845.x","article-title":"Serum Plakophilin-3 Autoreactivity in Paraneoplastic Pemphigus","volume":"163","author":"Lambert","year":"2010","journal-title":"Br. J. Dermatol."},{"key":"B203","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/exd.12355","article-title":"Specific Immunoadsorption of Pathogenic Autoantibodies in Pemphigus Requires the Entire Ectodomains of Desmogleins","volume":"23","author":"Langenhan","year":"2014","journal-title":"Exp. Dermatol."},{"key":"B204","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1159\/000018030","article-title":"HLA Class II Allele Associations in Korean Patients with Pemphigus","volume":"197","author":"Lee","year":"1998","journal-title":"Dermatology"},{"key":"B205","doi-asserted-by":"publisher","first-page":"12524","DOI":"10.1074\/jbc.M808204200","article-title":"Biphasic Activation of p38MAPK Suggests that Apoptosis Is a Downstream Event in Pemphigus Acantholysis","volume":"284","author":"Lee","year":"2009","journal-title":"J. Biol. Chem."},{"key":"B206","doi-asserted-by":"publisher","first-page":"438","DOI":"10.5021\/ad.2017.29.4.438","article-title":"Analysis of Serum Cytokine Profile in Pemphigus","volume":"29","author":"Lee","year":"2017","journal-title":"Ann. Dermatol."},{"key":"B207","doi-asserted-by":"publisher","first-page":"6317","DOI":"10.1172\/JCI138416","article-title":"Antigen-specific B Cell Depletion for Precision Therapy of Mucosal Pemphigus Vulgaris","volume":"130","author":"Lee","year":"2020","journal-title":"J. Clin. Invest."},{"key":"B208","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1001\/archdermatol.2012.1830","article-title":"Prognostic Factors of Paraneoplastic Pemphigus","volume":"148","author":"Leger","year":"2012","journal-title":"Arch. Dermatol."},{"key":"B209","first-page":"549","article-title":"Pemphigus Vegetans, a Clinical Type of Chronic Pustular Dermatitis of Hallopeau","volume":"109","author":"Leroy","year":"1982","journal-title":"Ann. Dermatol. Venereol."},{"key":"B210","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1080\/08820139.2017.1385622","article-title":"Association between HLA-DQB1 Polymorphisms and Pemphigus Vulgaris: A Meta-Analysis","volume":"47","author":"Li","year":"2018","journal-title":"Immunological Invest."},{"key":"B211","doi-asserted-by":"publisher","first-page":"965","DOI":"10.3389\/fimmu.2019.00965","article-title":"Survival of Long-Lived Plasma Cells (LLPC): Piecing Together the Puzzle","volume":"10","author":"Lightman","year":"2019","journal-title":"Front. Immunol."},{"key":"B212","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1172\/JCI119130","article-title":"Development and Characterization of Desmoglein-3 Specific T Cells from Patients with Pemphigus Vulgaris","volume":"99","author":"Lin","year":"1997","journal-title":"J. Clin. Invest."},{"key":"B213","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1111\/j.1365-2133.2007.08361.x","article-title":"Genotyping of HLA-I and HLA-II Alleles in Chinese Patients with Paraneoplastic Pemphigus","volume":"158","author":"Liu","year":"2008","journal-title":"Br. J. Dermatol."},{"key":"B214","doi-asserted-by":"publisher","first-page":"e452","DOI":"10.1111\/ajd.13355","article-title":"Pemphigus Vegetans Localised to the Soles of Both Feet: Successful Clearance with Intralesional Corticosteroid","volume":"61","author":"Liu","year":"2020","journal-title":"Australas. J. Dermatol."},{"key":"B215","doi-asserted-by":"publisher","first-page":"e0156800","DOI":"10.1371\/journal.pone.0156800","article-title":"Pathogenicity and Epitope Characteristics Do Not Differ in IgG Subclass-Switched Anti-desmoglein 3 IgG1 and IgG4 Autoantibodies in Pemphigus Vulgaris","volume":"11","author":"Lo","year":"2016","journal-title":"PLoS ONE"},{"key":"B216","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1006\/jaut.2000.0388","article-title":"HLA Class II Polymorphism Contributes to Specify Desmoglein Derived Peptides in Pemphigus Vulgaris and Pemphigus Foliaceus","volume":"15","author":"Loiseau","year":"2000","journal-title":"J. Autoimmun."},{"key":"B217","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1159\/000247321","article-title":"Imbalance between Plasminogen Activator and its Inhibitors in Thiol-Lnduced Acantholysis","volume":"186","author":"Lombardi","year":"1993","journal-title":"Dermatology"},{"key":"B218","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1046\/j.1523-1747.1999.00626.x","article-title":"Common Human Leukocyte Antigen Alleles in Pemphigus Vulgaris and Pemphigus Foliaceus Italian Patients","volume":"113","author":"Lombardi","year":"1999","journal-title":"J. Invest. Dermatol."},{"key":"B219","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/0030-4220(94)90318-2","article-title":"Double-blind Clinical Trial of 0.05% Clobetasol Propionate (Corrected from Proprionate) Ointment in Orabase and 0.05% Fluocinonide Ointment in Orabase in the Treatment of Patients with Oral Vesiculoerosive Diseases","volume":"77","author":"Lozada-Nur","year":"1994","journal-title":"Oral Surg. Oral Med. Oral Pathol."},{"key":"B220","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.13755","article-title":"An Unusual Presentation of Pemphigus Foliaceus Following COVID\u201019 Vaccination","author":"Lua","year":"2021","journal-title":"Australas. J. Dermatol."},{"key":"B221","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.jaci.2012.03.022","article-title":"Inhibitory Human Antichimeric Antibodies to Rituximab in a Patient with Pemphigus","volume":"130","author":"Lunardon","year":"2012","journal-title":"J. Allergy Clin. Immunol."},{"key":"B222","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/nri2729","article-title":"Effector and Regulatory B Cells: Modulators of CD4+ T Cell Immunity","volume":"10","author":"Lund","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"B223","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1365-2133.1996.tb07848.x","article-title":"Pemphigus in Mali: a Study of 30 Cases","volume":"134","author":"Mah\u00e9","year":"1996","journal-title":"Br. J. Dermatol."},{"key":"B224","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1046\/j.1523-1747.1998.00279.x","article-title":"The Members of the Plakin Family of Proteins Recognized by Paraneoplastic Pemphigus Antibodies Include Periplakin","volume":"111","author":"Mahoney","year":"1998","journal-title":"J. Invest. Dermatol."},{"key":"B225","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1172\/JCI5252","article-title":"Explanations for the Clinical and Microscopic Localization of Lesions in Pemphigus Foliaceus and Vulgaris","volume":"103","author":"Mahoney","year":"1999","journal-title":"J. Clin. Invest."},{"key":"B226","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1016\/j.jid.2021.01.031","article-title":"Rituximab and Corticosteroid Effect on Desmoglein-specific B Cells and Desmoglein-specific T Follicular Helper Cells in Pemphigus","volume":"141","author":"Maho-Vaillant","year":"2021","journal-title":"J. Invest. Dermatol."},{"key":"B227","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1111\/bjd.14877","article-title":"Paraneoplastic Pemphigus with Anti-bp180 Autoantibodies and Castleman Disease","volume":"176","author":"Maier","year":"2017","journal-title":"Br. J. Dermatol."},{"key":"B228","doi-asserted-by":"publisher","first-page":"487","DOI":"10.2340\/00015555-1781","article-title":"Induction of Skin Lesions by Ultraviolet B Irradiation in a Case of Pemphigus Erythematosus","volume":"94","author":"Makino","year":"2014","journal-title":"Acta Derm Venerol"},{"key":"B229","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1159\/000099588","article-title":"Concurrence of Systemic Lupus Erythematosus and Pemphigus: Coincidence or Correlation?","volume":"214","author":"Malik","year":"2007","journal-title":"Dermatology"},{"key":"B230","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1074\/jbc.M110.172874","article-title":"p38 MAPK Activation Is Downstream of the Loss of Intercellular Adhesion in Pemphigus Vulgaris","volume":"286","author":"Mao","year":"2011","journal-title":"J. Biol. Chem."},{"key":"B231","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/s0896-8411(02)00092-6","article-title":"Paraneoplastic Pemphigus Is Associated with the DRB1*03 Allele","volume":"20","author":"Martel","year":"2003","journal-title":"J. Autoimmun."},{"key":"B232","doi-asserted-by":"publisher","first-page":"CD006263","DOI":"10.1002\/14651858.CD006263.pub2","article-title":"Interventions for Pemphigus Vulgaris and Pemphigus Foliaceus","volume":"21","author":"Martin","year":"2009","journal-title":"Cochrane Database Syst. Rev."},{"key":"B233","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1172\/JCI85113","article-title":"Human Regulatory B Cells in Health and Disease: Therapeutic Potential","volume":"127","author":"Mauri","year":"2017","journal-title":"J. Clin. Invest."},{"key":"B234","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1159\/000468919","article-title":"Atypical Clinical and Serological Manifestation of Pemphigus Vegetans: A Case Report and Review of the Literature","volume":"9","author":"Mergler","year":"2017","journal-title":"Case Rep. Dermatol."},{"key":"B235","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1001\/jamadermatol.2020.0290","article-title":"Factors Associated with Short-Term Relapse in Patients with Pemphigus Who Receive Rituximab as First-Line Therapy","volume":"156","author":"Mignard","year":"2020","journal-title":"JAMA Dermatol."},{"key":"B236","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1046\/j.1365-4362.2000.00051-5.x","article-title":"Pemphigus Induction by Influenza Vaccination","volume":"39","author":"Mignogna","year":"2000","journal-title":"Int. J. Dermatol."},{"key":"B237","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1111\/exd.13409","article-title":"Routine Detection of Serum Antidesmocollin Autoantibodies Is Only Useful in Patients with Atypical Pemphigus","volume":"26","author":"Mindorf","year":"2017","journal-title":"Exp. Dermatol."},{"key":"B238","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.det.2011.03.022","article-title":"Clinical Features, Diagnosis, and Pathogenesis of Chronic Bullous Disease of Childhood","volume":"29","author":"Mintz","year":"2011","journal-title":"Dermatol. Clin."},{"key":"B239","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1046\/j.1365-2133.2002.04564.x","article-title":"Genotyping for HLA-A, B and C Alleles in Japanese Patients with Pemphigus: Prevalence of Asian Alleles of the HLA-B15 Family","volume":"146","author":"Miyagawa","year":"2002","journal-title":"Br. J. Dermatol."},{"key":"B240","doi-asserted-by":"publisher","first-page":"102736","DOI":"10.1016\/j.autrev.2020.102736","article-title":"B Cell Activating Factor (BAFF): Structure, Functions, Autoimmunity and Clinical Implications in Systemic Lupus Erythematosus (SLE)","volume":"20","author":"M\u00f6ckel","year":"2021","journal-title":"Autoimmun. Rev."},{"key":"B241","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.3892\/or.2019.7335","article-title":"CAR T Cell Therapy: A new era for Cancer Treatment (Review)","volume":"42","author":"Mohanty","year":"2019","journal-title":"Oncol. Rep."},{"key":"B242","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1159\/000111506","article-title":"Stressful Life Events and Pemphigus","volume":"216","author":"Morell-Dubois","year":"2008","journal-title":"Dermatology"},{"key":"B243","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1001\/archderm.1993.01680220081019","article-title":"Pemphigus Foliaceus in Young Women","volume":"129","author":"Morini","year":"1993","journal-title":"Arch. Dermatol."},{"key":"B244","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.immuni.2010.12.012","article-title":"Human Blood CXCR5+CD4+ T Cells Are Counterparts of T Follicular Cells and Contain Specific Subsets that Differentially Support Antibody Secretion","volume":"34","author":"Morita","year":"2011","journal-title":"Immunity"},{"key":"B245","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.humimm.2012.02.001","article-title":"Tumor Necrosis Factor-\u03b1 -308 G>A and Interleukin-6 -174 G>C Promoter Polymorphisms and Pemphigus","volume":"73","author":"Mosaad","year":"2012","journal-title":"Hum. Immunol."},{"key":"B246","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1038\/jid.2008.178","article-title":"B-cell Depletion Immunotherapy in Pemphigus: Effects on Cellular and Humoral Immune Responses","volume":"128","author":"Mouquet","year":"2008","journal-title":"J. Invest. Dermatol."},{"key":"B247","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1111\/j.1365-2230.2009.03241.x","article-title":"Autoantibodies against Desmocollins in European Patients with Pemphigus","volume":"34","author":"M\u00fcller","year":"2009","journal-title":"Clin. Exp. Dermatol."},{"key":"B248","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2010\/321950","article-title":"Targeted Immunotherapy with Rituximab Leads to a Transient Alteration of the IgG Autoantibody Profile in Pemphigus Vulgaris","volume":"2010","author":"M\u00fcller","year":"2010","journal-title":"Dermatol. Res. Pract."},{"key":"B249","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1111\/j.1346-8138.1996.tb02652.x","article-title":"Pemphigus Vulgaris Exacerbated by Exposure to Sunlight","volume":"23","author":"Muramatsu","year":"1996","journal-title":"J. Dermatol."},{"key":"B250","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1111\/bjd.20431","article-title":"Proof of Concept for the Clinical Effects of Oral Rilzabrutinib, the First Bruton Tyrosine Kinase Inhibitor for Pemphigus Vulgaris: the Phase II BELIEVE Study*","volume":"185","author":"Murrell","year":"2021","journal-title":"Br. J. Dermatol."},{"key":"B251","doi-asserted-by":"publisher","first-page":"3106","DOI":"10.4049\/jimmunol.0902661","article-title":"Mechanism of T Cell Tolerance Induced by Myeloid-Derived Suppressor Cells","volume":"184","author":"Nagaraj","year":"2010","journal-title":"J.I."},{"key":"B252","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1172\/JCI20480","article-title":"Defining the Pathogenic Involvement of Desmoglein 4 in Pemphigus and Staphylococcal Scalded Skin Syndrome","volume":"114","author":"Nagasaka","year":"2004","journal-title":"J. Clin. Invest."},{"key":"B253","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1111\/exd.14298","article-title":"Arginase 1 + IL\u201010 + Polymorphonuclear Myeloid\u2010derived Suppressor Cells Are Elevated in Patients with Active Pemphigus and Correlate with an Increased Th2\/Th1 Response","volume":"30","author":"Neri","year":"2021","journal-title":"Exp. Dermatol."},{"key":"B254","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1001\/archderm.134.8.971","article-title":"The Pathophysiological Significance of Nondesmoglein Targets of Pemphigus Autoimmunity","volume":"134","author":"Nguyen","year":"1998","journal-title":"Arch. Dermatol."},{"key":"B255","doi-asserted-by":"publisher","first-page":"29466","DOI":"10.1074\/jbc.M003174200","article-title":"Pemphigus Vulgaris Antibody Identifies Pemphaxin","volume":"275","author":"Nguyen","year":"","journal-title":"J. Biol. Chem."},{"key":"B256","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1172\/JCI10305","article-title":"Antibodies against Keratinocyte Antigens Other Than Desmogleins 1 and 3 Can Induce Pemphigus Vulgaris-like Lesions","volume":"106","author":"Nguyen","year":"","journal-title":"J. Clin. Invest."},{"key":"B257","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.jdermsci.2004.08.006","article-title":"Exclusion of the TAP1 and TAP2 Genes within the HLA Class II Region as Candidate Susceptibility Genes to Pemphigus in the Japanese Population","volume":"36","author":"Niizeki","year":"2004","journal-title":"J. Dermatol. Sci."},{"key":"B258","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1111\/j.1365-2230.1991.tb00413.x","article-title":"The Clinical and Histopathological Spectrum of IgA Pemphigus","volume":"16","author":"Nishikawa","year":"1991","journal-title":"Clin. Exp. Dermatol."},{"key":"B259","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.clml.2011.04.005","article-title":"Hepatitis C Reactivation in Patients Who Have Diffuse Large B-Cell Lymphoma Treated with Rituximab: A Case Report and Review of Literature","volume":"11","author":"Nooka","year":"2011","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"B260","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1038\/jid.2013.65","article-title":"Anti-Alpha-2-Macroglobulin-Like-1 Autoantibodies Are Detected Frequently and May Be Pathogenic in Paraneoplastic Pemphigus","volume":"133","author":"Numata","year":"2013","journal-title":"J. Invest. Dermatol."},{"key":"B261","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.3390\/jcm8091325","article-title":"The Role of Neutrophils and Neutrophil Extracellular Traps in Vascular Damage in Systemic Lupus Erythematosus","volume":"8","author":"O\u2019Neil","year":"2019","journal-title":"JCM"},{"key":"B262","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/7350759","article-title":"Paraneoplastic Pemphigus Involving the Respiratory and Gastrointestinal Mucosae","volume":"2020","author":"Odani","year":"2020","journal-title":"Case Rep. Pathol."},{"key":"B263","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1001\/jamadermatol.2013.1916","article-title":"Coexistence of Pemphigus Herpetiformis with IgG Antibodies to Desmocollin 1 and Pemphigoid with IgG Antibodies to BP180 C-Terminal Domain and Laminin \u03b32","volume":"149","author":"Ohata","year":"2013","journal-title":"JAMA Dermatol."},{"key":"B264","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1046\/j.0022-202x.2001.01643.x","article-title":"Immunologic and Histopathologic Characterization of an Active Disease Mouse Model for Pemphigus Vulgaris","volume":"118","author":"Ohyama","year":"2002","journal-title":"J. Invest. Dermatol."},{"key":"B265","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1111\/bjd.14162","article-title":"Clinical and Immunological Findings in 104 Cases of Paraneoplastic Pemphigus","volume":"173","author":"Ohzono","year":"2015","journal-title":"Br. J. Dermatol."},{"key":"B266","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1001\/archdermatol.2012.1896","article-title":"The IgG \"Lupus-Band\" Deposition Pattern of Pemphigus Erythematosus","volume":"148","author":"Oktarina","year":"2012","journal-title":"Arch. Dermatol."},{"key":"B267","first-page":"100","article-title":"Evaluation of the Importance of Immunological Profile for Pemphigus Vulgaris in the Light of Necessity to Modify Compensation Theory","volume":"26","author":"\u00d6ktem","year":"2018","journal-title":"Acta Dermatovenerol Croat."},{"key":"B268","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.jid.2020.07.015","article-title":"Clinical Relevance of Polymorphonuclear Myeloid-Derived Suppressor Cells in Autoimmune-Blistering Disorders Pemphigus Vulgaris and Bullous Pemphigoid","volume":"141","author":"Oktem","year":"2021","journal-title":"J. Invest. Dermatol."},{"key":"B269","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1111\/bjd.12455","article-title":"E-cadherin Autoantibody Profile in Patients with Pemphigus Vulgaris","volume":"169","author":"Oliveira","year":"2013","journal-title":"Br. J. Dermatol."},{"key":"B270","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1111\/bjd.13419","article-title":"Pemphigus Herpetiformis with IgG Autoantibodies to Desmoglein 1 and Desmocollin 1","volume":"172","author":"On","year":"2015","journal-title":"Br. J. Dermatol."},{"key":"B271","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S0190-9622(97)80213-7","article-title":"Infertility in Women with Pemphigus Vulgaris and Other Autoimmune Diseases","volume":"36","author":"Ouahes","year":"1997","journal-title":"J. Am. Acad. Dermatol."},{"key":"B272","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.3390\/ijms18122532","article-title":"Paraneoplastic Pemphigus: Insight into the Autoimmune Pathogenesis, Clinical Features and Therapy","volume":"18","author":"Paolino","year":"2017","journal-title":"IJMS"},{"key":"B273","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1111\/iji.12052","article-title":"High Susceptibility to Pemphigus Vulgaris Due to HLA-Drb1*14:54 in the Slovak Population","volume":"40","author":"P\u00e1rnick\u00e1","year":"2013","journal-title":"Int. J. Immunogenet."},{"key":"B274","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1111\/j.1365-4362.1995.tb04430.x","article-title":"Dexamethasone-Cyclophosphamide Pulse Therapy for Pemphigus","volume":"34","author":"Pasricha","year":"1995","journal-title":"Int. J. Dermatol."},{"key":"B275","doi-asserted-by":"publisher","first-page":"954","DOI":"10.4254\/wjh.v7.i7.954","article-title":"Hepatitis B Reactivation in the Setting of Chemotherapy and Immunosuppression - Prevention Is Better Than Cure","volume":"7","author":"Pattullo","year":"2015","journal-title":"WJH"},{"key":"B276","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1172\/JCI24185","article-title":"Genetic and Functional Characterization of Human Pemphigus Vulgaris Monoclonal Autoantibodies Isolated by Phage Display","volume":"115","author":"Payne","year":"2005","journal-title":"J. Clin. Invest."},{"key":"B277","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.cyto.2004.08.006","article-title":"Cytokine Gene Polymorphisms in Endemic Pemphigus Foliaceus: a Possible Role for IL6 Variants","volume":"28","author":"Pereira","year":"2004","journal-title":"Cytokine"},{"key":"B278","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/296214","article-title":"Autoantibodies in Senear-Usher Syndrome: Cross-Reactivity or Multiple Autoimmunity?","volume":"2012","author":"P\u00e9rez-P\u00e9rez","year":"20122012","journal-title":"Autoimmune Dis."},{"key":"B279","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1177\/0192623311430693","article-title":"Regulatory T-Cells: Diverse Phenotypes Integral to Immune Homeostasis and Suppression","volume":"40","author":"Peterson","year":"2012","journal-title":"Toxicol. Pathol."},{"key":"B280","doi-asserted-by":"publisher","first-page":"e20190369","DOI":"10.1590\/1678-4685-gmb-2019-0369","article-title":"Beyond the HLA Polymorphism: A Complex Pattern of Genetic Susceptibility to Pemphigus","volume":"43","author":"Petzl-Erler","year":"2020","journal-title":"Genet. Mol. Biol."},{"key":"B281","doi-asserted-by":"publisher","first-page":"227","DOI":"10.3389\/fmed.2018.00227","article-title":"Involvement of Nail Apparatus in Pemphigus Vulgaris in Ethnic Poles Is Infrequent","volume":"5","author":"Pietkiewicz","year":"2018","journal-title":"Front. Med."},{"key":"B282","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12016-017-8662-z","article-title":"Pemphigus: a Comprehensive Review on Pathogenesis, Clinical Presentation and Novel Therapeutic Approaches","volume":"54","author":"Pollmann","year":"2018","journal-title":"Clinic Rev. Allerg Immunol."},{"key":"B283","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1590\/abd1806-4841.2019940206","article-title":"Consensus on the Treatment of Autoimmune Bullous Dermatoses: Pemphigus Vulgaris and Pemphigus Foliaceus - Brazilian Society of Dermatology","volume":"94","author":"Porro","year":"2019","journal-title":"Bras. Dermatol."},{"key":"B284","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.cca.2009.08.022","article-title":"Development of ELISA for the Specific Determination of Autoantibodies against Envoplakin and Periplakin in Paraneoplastic Pemphigus","volume":"410","author":"Probst","year":"2009","journal-title":"Clinica Chim. Acta"},{"key":"B285","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1046\/j.1523-1747.2003.12014.x","article-title":"Fas Ligand in Pemphigus Sera Induces Keratinocyte Apoptosis through the Activation of Caspase-8","volume":"120","author":"Puviani","year":"2003","journal-title":"J. Invest. Dermatol."},{"key":"B286","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.3389\/fimmu.2019.01540","article-title":"The Neonatal Fc Receptor (FcRn): A Misnomer?","volume":"10","author":"Pyzik","year":"2019","journal-title":"Front. Immunol."},{"key":"B287","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.4049\/jimmunol.1200842","article-title":"Cutting Edge: Brazilian Pemphigus Foliaceus Anti-desmoglein 1 Autoantibodies Cross-React with Sand Fly Salivary LJM11 Antigen","volume":"189","author":"Qian","year":"2012","journal-title":"J.I."},{"key":"B288","doi-asserted-by":"publisher","first-page":"770","DOI":"10.3389\/fimmu.2019.00770","article-title":"ST18 Enhances PV-IgG-Induced Loss of Keratinocyte Cohesion in Parallel to Increased ERK Activation","volume":"10","author":"Radeva","year":"2019","journal-title":"Front. Immunol."},{"key":"B289","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.ajpath.2010.10.016","article-title":"IgG Autoantibodies against Desmocollin 3 in Pemphigus Sera Induce Loss of Keratinocyte Adhesion","volume":"178","author":"Rafei","year":"2011","journal-title":"Am. J. Pathol."},{"key":"B290","doi-asserted-by":"publisher","first-page":"454","DOI":"10.5021\/ad.2019.31.4.454","article-title":"Possible Role for Plasmacytoid Dendritic Cells in Pemphigus","volume":"31","author":"Ramadan","year":"2019","journal-title":"Ann. Dermatol."},{"key":"B291","first-page":"1338","article-title":"Successful Treatment of Pemphigus Vulgaris with Ofatumumab","volume":"17","author":"Rapp","year":"2018","journal-title":"J. Drugs Dermatol."},{"key":"B292","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S0190-9622(82)70111-2","article-title":"Death in Pemphigus","volume":"7","author":"Razzaque Ahmed","year":"1982","journal-title":"J. Am. Acad. Dermatol."},{"key":"B293","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1053\/j.gastro.2014.10.039","article-title":"American Gastroenterological Association Institute Guideline on the Prevention and Treatment of Hepatitis B Virus Reactivation during Immunosuppressive Drug Therapy","volume":"148","author":"Reddy","year":"2015","journal-title":"Gastroenterology"},{"key":"B294","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1067\/mjd.2000.104891","article-title":"UVB-induced Acantholysis in Endemic Pemphigus Foliaceus (Fogo Selvagem) and Pemphigus Vulgaris","volume":"42","author":"Reis","year":"2000","journal-title":"J. Am. Acad. Dermatol."},{"key":"B295","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/ced.13650","article-title":"Association between Climate, Pollution and Hospitalization for Pemphigus in the USA","volume":"44","author":"Ren","year":"2019","journal-title":"Clin. Exp. Dermatol."},{"key":"B296","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1111\/j.1365-2230.2005.01836.x","article-title":"Direct Characterization of Human T Cells in Pemphigus Vulgaris Reveals Elevated Autoantigen-specific Th2 Activity in Association with Active Disease","volume":"30","author":"Rizzo","year":"2005","journal-title":"Clin. Exp. Dermatol."},{"key":"B297","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1159\/000250097","article-title":"Pemphigus Provoked by D(-)Penicillamine","volume":"164","author":"Ruocco","year":"1982","journal-title":"Dermatology"},{"key":"B298","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/0738-081x(93)90158-9","article-title":"Drug-induced Pemphigus. II. Pathomechanisms and Experimental Investigations","volume":"11","author":"Ruocco","year":"1993","journal-title":"Clin. Dermatol."},{"key":"B299","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1046\/j.1365-4362.2001.01099.x","article-title":"Pemphigus and Diet: Does a Link Exist?","volume":"40","author":"Ruocco","year":"2001","journal-title":"Int. J. Dermatol."},{"key":"B300","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/945950","article-title":"Rituximab-Based Treatment, HCV Replication, and Hepatic Flares","volume":"2012","author":"Sagnelli","year":"20122012","journal-title":"Clin. Develop. Immunol."},{"key":"B301","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1111\/j.1365-2133.2009.09590.x","article-title":"Pulsed Intravenous Cyclophosphamide and Methylprednisolone Therapy in Refractory Pemphigus","volume":"162","author":"Saha","year":"2009","journal-title":"Br. J. Dermatol."},{"key":"B302","doi-asserted-by":"publisher","first-page":"e50696","DOI":"10.1371\/journal.pone.0050696","article-title":"Signaling Dependent and Independent Mechanisms in Pemphigus Vulgaris Blister Formation","volume":"7","author":"Saito","year":"2012","journal-title":"PLoS ONE"},{"key":"B303","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.4049\/jimmunol.155.3.1151","article-title":"Immunologic Self-Tolerance Maintained by Activated T Cells Expressing IL-2 Receptor Alpha-Chains (CD25). Breakdown of a Single Mechanism of Self-Tolerance Causes Various Autoimmune Diseases","volume":"155","author":"Sakaguchi","year":"1995","journal-title":"J. Immunol."},{"key":"B304","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1111\/1346-8138.12888","article-title":"Low Pathogenicity of Anti-desmoglein 3 Immunoglobulin G Autoantibodies Contributes to the Atypical Clinical Phenotypes in Pemphigus","volume":"42","author":"Saleh","year":"2015","journal-title":"J. Dermatol."},{"key":"B305","first-page":"623","article-title":"Incidence of Pemphigus in Newborn Infants Born at the Gynecologic-Obstetrical Department in Bijeljina","volume":"29","author":"Salihbegovi\u0107-Opali\u0107","year":"1975","journal-title":"Med. Arh"},{"key":"B306","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1067\/mjd.2002.126273","article-title":"Anti-CD20 Chimeric Monoclonal Antibody (Rituximab) for the Treatment of Recalcitrant, Life-Threatening Pemphigus Vulgaris with Implications in the Pathogenesis of the Disorder","volume":"47","author":"Salopeka","year":"2002","journal-title":"J. Am. Acad. Dermatol."},{"key":"B307","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1111\/bjd.12012","article-title":"Is There an Emergent Need to Modify the Desmoglein Compensation Theory in Pemphigus on the Basis of Dsg ELISA Data and Alternative Pathogenic Mechanisms?","volume":"168","author":"Sardana","year":"2013","journal-title":"Br. J. Dermatol."},{"key":"B308","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1038\/jid.2012.46","article-title":"Population-Specific Association between a Polymorphic Variant in ST18, Encoding a Pro-apoptotic Molecule, and Pemphigus Vulgaris","volume":"132","author":"Sarig","year":"2012","journal-title":"J. Invest. Dermatol."},{"key":"B309","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1080\/08820130902943097","article-title":"Involvement of TH1\/TH2 Cytokines in the Pathogenesis of Autoimmune Skin Disease-Pemphigus Vulgaris","volume":"38","author":"Satyam","year":"2009","journal-title":"Immunological Invest."},{"key":"B310","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.abd.2020.12.009","article-title":"Evaluation of Non-endemic Pemphigus Foliaceus in a Large Series of Patients: a Single-center Retrospective Study from Turkey Focuses on the Relapses","volume":"96","author":"Sayar","year":"2021","journal-title":"Anais Brasileiros de Dermatologia"},{"key":"B311","doi-asserted-by":"publisher","first-page":"e12250","DOI":"10.1371\/journal.pone.0012250","article-title":"The Protease Inhibitor Alpha-2-Macroglobuline-Like-1 Is the P170 Antigen Recognized by Paraneoplastic Pemphigus Autoantibodies in Human","volume":"5","author":"Schepens","year":"2010","journal-title":"PLoS ONE"},{"key":"B312","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/j.1600-0625.2010.01069.x","article-title":"Novel ELISA Systems for Antibodies to Desmoglein 1 and 3: Correlation of Disease Activity with Serum Autoantibody Levels in Individual Pemphigus Patients","volume":"19","author":"Schmidt","year":"2010","journal-title":"Exp. Dermatol."},{"key":"B313","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/exd.12919","article-title":"Induction of T Regulatory Cells by the Superagonistic Anti-CD28 Antibody D665 Leads to Decreased Pathogenic IgG Autoantibodies against Desmoglein 3 in a HLA-Transgenic Mouse Model of Pemphigus Vulgaris","volume":"25","author":"Schmidt","year":"2016","journal-title":"Exp. Dermatol."},{"key":"B314","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/S0140-6736(19)31778-7","article-title":"Pemphigus","volume":"394","author":"Schmidt","year":"2019","journal-title":"The Lancet"},{"key":"B315","doi-asserted-by":"publisher","first-page":"701809","DOI":"10.3389\/fmed.2021.701809","article-title":"Autoantibody-Specific Signalling in Pemphigus","volume":"8","author":"Schmitt","year":"2021","journal-title":"Front. Med."},{"key":"B316","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/jid.2011.299","article-title":"An Adult Passive Transfer Mouse Model to Study Desmoglein 3 Signaling in Pemphigus Vulgaris","volume":"132","author":"Schulze","year":"2012","journal-title":"J. Invest. Dermatol."},{"key":"B317","doi-asserted-by":"publisher","first-page":"5439","DOI":"10.4049\/jimmunol.167.9.5439","article-title":"Dominant Autoimmune Epitopes Recognized by Pemphigus Antibodies Map to the N-Terminal Adhesive Region of Desmogleins","volume":"167","author":"Sekiguchi","year":"2001","journal-title":"J. Immunol."},{"key":"B318","first-page":"E622","article-title":"Pemphigus Vulgaris in Oral Cavity: Clinical Analysis of 71 Cases","volume":"13","author":"Shamim","year":"2008","journal-title":"Med. Oral Patol Oral Cir Bucal"},{"key":"B319","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s10875-008-9244-x","article-title":"HLA Class II (DRB, DQA1 and DQB1) Allele and Haplotype Frequencies in the Patients with Pemphigus Vulgaris","volume":"29","author":"Shams","year":"2009","journal-title":"J. Clin. Immunol."},{"key":"B320","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s00281-020-00827-8","article-title":"Control of Immunity by Glucocorticoids in Health and Disease","volume":"42","author":"Shimba","year":"2020","journal-title":"Semin. Immunopathol"},{"key":"B321","first-page":"181","article-title":"Vaccination as an Additional Player in the Mosaic of Autoimmunity","volume":"18","author":"Shoenfeld","year":"2000","journal-title":"Clin. Exp. Rheumatol."},{"key":"B322","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/j.humimm.2005.11.004","article-title":"Pemphigus Vulgaris Is Associated with the Transporter Associated with Antigen Processing (TAP) System","volume":"66","author":"Slomov","year":"2005","journal-title":"Hum. Immunol."},{"key":"B323","doi-asserted-by":"publisher","first-page":"e649","DOI":"10.1111\/jdv.17480","article-title":"Development of Severe Pemphigus Vulgaris Following SARS\u2010CoV\u20102 Vaccination with BNT162b2","volume":"35","author":"Solimani","year":"2021","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"B324","doi-asserted-by":"publisher","first-page":"30556","DOI":"10.1074\/jbc.M109.024810","article-title":"Desmocollin 3-mediated Binding Is Crucial for Keratinocyte Cohesion and Is Impaired in Pemphigus","volume":"284","author":"Spindler","year":"2009","journal-title":"J. Biol. Chem."},{"key":"B325","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jid.2017.06.022","article-title":"Mechanisms Causing Loss of Keratinocyte Cohesion in Pemphigus","volume":"138","author":"Spindler","year":"2018","journal-title":"J. Invest. Dermatol."},{"key":"B326","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1056\/NEJM200109273451315","article-title":"Fatal Reactivation of Cytomegalovirus Infection after Use of Rituximab for a Post-Transplantation Lymphoproliferative Disorder","volume":"345","author":"Suzan","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"B327","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/s41584-018-0044-2","article-title":"IL-17 in the Immunopathogenesis of Spondyloarthritis","volume":"14","author":"Taams","year":"2018","journal-title":"Nat. Rev. Rheumatol."},{"key":"B328","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.4049\/jimmunol.181.2.1526","article-title":"Novel System Evaluating In Vivo Pathogenicity of Desmoglein 3-reactive T Cell Clones Using Murine Pemphigus Vulgaris","volume":"181","author":"Takahashi","year":"2008","journal-title":"J. Immunol."},{"key":"B329","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/j.jdcr.2020.08.035","article-title":"Autoimmune Bullous Disease in Skin of Color: A Case Series","volume":"6","author":"Tamazian","year":"2020","journal-title":"JAAD Case Rep."},{"key":"B330","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.clindermatol.2016.05.021","article-title":"Pemphigus Vulgaris and Pemphigus Foliaceus Determined by CD86 and CTLA4 Polymorphisms","volume":"35","author":"Tanasilovic","year":"2017","journal-title":"Clin. Dermatol."},{"key":"B331","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1111\/ced.13355","article-title":"Pemphigus Herpetiformis with Autoantibodies to Desmocollins 1, 2 and 3","volume":"43","author":"Tay","year":"2018","journal-title":"Clin. Exp. Dermatol."},{"key":"B332","doi-asserted-by":"publisher","DOI":"10.1111\/odi.14034","article-title":"Oral Pemphigus after COVID\u201019 Vaccination","author":"Thongprasom","year":"2021","journal-title":"Oral Dis."},{"key":"B333","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/7151285","article-title":"Th1\/Th17-Related Cytokines and Chemokines and Their Implications in the Pathogenesis of Pemphigus Vulgaris","volume":"2017","author":"Timoteo","year":"20172017","journal-title":"Mediators Inflamm."},{"key":"B334","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1080\/09629350310001619735","article-title":"Tumour Necrosis Factor-\u03b1 Polymorphism as One of the Complex Inherited Factors in Pemphigus","volume":"12","author":"Torzecka","year":"2003","journal-title":"Mediators Inflamm."},{"key":"B335","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.humimm.2013.01.009","article-title":"Cytokine Gene Polymorphisms in Tunisian Endemic Pemphigus Foliaceus: a Possible Role of Il-4 Variants","volume":"74","author":"Toumi","year":"2013","journal-title":"Hum. Immunol."},{"key":"B336","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1080\/08916930600971497","article-title":"Immunogenetics of Pemphigus: an Update","volume":"39","author":"Tron","year":"2006","journal-title":"Autoimmunity"},{"key":"B337","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1046\/j.1365-4362.2000.00864.x","article-title":"Epidemiology of Pemphigus in Sofia, Bulgaria. A 16-year Retrospective Study (1980-1995)","volume":"39","author":"Tsankov","year":"2000","journal-title":"Int. J. Dermatol."},{"key":"B338","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/JID.2015.408","article-title":"Epiplakin Is a Paraneoplastic Pemphigus Autoantigen and Related to Bronchiolitis Obliterans in Japanese Patients","volume":"136","author":"Tsuchisaka","year":"2016","journal-title":"J. Invest. Dermatol."},{"key":"B339","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.4049\/jimmunol.170.4.2170","article-title":"Induction of Pemphigus Phenotype by a Mouse Monoclonal Antibody against the Amino-Terminal Adhesive Interface of Desmoglein 3","volume":"170","author":"Tsunoda","year":"2003","journal-title":"J. Immunol."},{"key":"B340","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.clindermatol.2011.01.014","article-title":"IgA Pemphigus","volume":"29","author":"Tsuruta","year":"2011","journal-title":"Clin. Dermatol."},{"key":"B341","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/j.1346-8138.2009.00743.x","article-title":"Association of Human Leukocyte Antigen Class II Alleles with Pemphigus Vulgaris in a Turkish Population","volume":"37","author":"Tunca","year":"2010","journal-title":"J. Dermatol."},{"key":"B342","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1001\/jamadermatol.2014.2087","article-title":"Blisters and Erosions in a Neonate","volume":"150","author":"Turrentine","year":"2014","journal-title":"JAMA Dermatol."},{"key":"B343","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1111\/bjd.12398","article-title":"Unique Herpetiform Bullous Dermatosis with IgG Antibodies to Desmocollins 1\/3 and LAD-1","volume":"169","author":"Ueda","year":"2013","journal-title":"Br. J. Dermatol."},{"key":"B344","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1111\/j.1365-2230.2007.02390.x","article-title":"Pemphigus and Associated Environmental Factors: a Case?control Study","volume":"32","author":"Valikhani","year":"2007","journal-title":"Clin. Exp. Dermatol."},{"key":"B345","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1111\/j.1365-4632.2008.03645.x","article-title":"Impact of Smoking on Pemphigus","volume":"47","author":"Valikhani","year":"2008","journal-title":"Int. J. Dermatol."},{"key":"B346","doi-asserted-by":"publisher","first-page":"635","DOI":"10.4049\/jimmunol.170.1.635","article-title":"Dichotomy of Autoreactive Th1 and Th2 Cell Responses to Desmoglein 3 in Patients with Pemphigus Vulgaris (PV) and Healthy Carriers of PV-Associated HLA Class II Alleles","volume":"170","author":"Veldman","year":"2003","journal-title":"J. Immunol."},{"key":"B347","doi-asserted-by":"publisher","first-page":"6468","DOI":"10.4049\/jimmunol.172.10.6468","article-title":"Type I Regulatory T Cells Specific for Desmoglein 3 Are More Frequently Detected in Healthy Individuals Than in Patients with Pemphigus Vulgaris","volume":"172","author":"Veldman","year":"2004","journal-title":"J. Immunol."},{"key":"B348","doi-asserted-by":"publisher","first-page":"3215","DOI":"10.4049\/jimmunol.176.5.3215","article-title":"Inhibition of the Transcription Factor Foxp3 Converts Desmoglein 3-Specific Type 1 Regulatory T Cells into Th2-like Cells","volume":"176","author":"Veldman","year":"2006","journal-title":"J. Immunol."},{"key":"B349","doi-asserted-by":"publisher","first-page":"87","DOI":"10.4103\/idoj.IDOJ_83_19","article-title":"A Rare Case of Extensive Pemphigus Vegetans","volume":"11","author":"Verma","year":"2020","journal-title":"Indian Dermatol. Online J."},{"key":"B350","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1001\/jamadermatol.2014.3674","article-title":"Intralesional Rituximab in the Treatment of Refractory Oral Pemphigus Vulgaris","volume":"151","author":"Vinay","year":"2015","journal-title":"JAMA Dermatol."},{"key":"B351","doi-asserted-by":"publisher","first-page":"e1006008","DOI":"10.1371\/journal.pgen.1006008","article-title":"Identification of a Functional Risk Variant for Pemphigus Vulgaris in the ST18 Gene","volume":"12","author":"Vodo","year":"2016","journal-title":"Plos Genet."},{"key":"B352","doi-asserted-by":"publisher","first-page":"226","DOI":"10.3389\/fmed.2018.00226","article-title":"The Genetics of Pemphigus Vulgaris","volume":"5","author":"Vodo","year":"2018","journal-title":"Front. Med."},{"key":"B353","doi-asserted-by":"publisher","first-page":"28820","DOI":"10.1038\/srep28820","article-title":"Loss of Flotillin Expression Results in Weakened Desmosomal Adhesion and Pemphigus Vulgaris-like Localisation of Desmoglein-3 in Human Keratinocytes","volume":"6","author":"V\u00f6llner","year":"2016","journal-title":"Sci. Rep."},{"key":"B354","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/jdv.13779","article-title":"Successful Monotherapy of Pemphigus Vegetans with Minocycline and Nicotinamide","volume":"31","author":"von K\u00f6ckritz","year":"2017","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"B355","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1056\/NEJM200007063430104","article-title":"The Prevalence of Antibodies against Desmoglein 1 in Endemic Pemphigus Foliaceus in Brazil","volume":"343","author":"Warren","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"B356","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.3389\/fimmu.2017.01454","article-title":"Bruton's Tyrosine Kinase: An Emerging Key Player in Innate Immunity","volume":"8","author":"Weber","year":"2017","journal-title":"Front. Immunol."},{"key":"B357","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1001\/archderm.144.1.25","article-title":"Multicenter Randomized, Double-Blind, Placebo-Controlled, Clinical Trial of Dapsone as a Glucocorticoid-Sparing Agent in Maintenance-phase Pemphigus Vulgaris","volume":"144","author":"Werth","year":"2008","journal-title":"Arch. Dermatol."},{"key":"B358","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.1016\/j.jid.2021.04.031","article-title":"Safety, Tolerability, and Activity of ALXN1830 Targeting the Neonatal Fc Receptor in Chronic Pemphigus","volume":"141","author":"Werth","year":"2021","journal-title":"J. Invest. Dermatol."},{"key":"B359","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1001\/archderm.1996.03890360021005","article-title":"Treatment of Pemphigus Vulgaris with Brief, High-Dose Intravenous Glucocorticoids","volume":"132","author":"Werth","year":"1996","journal-title":"Arch. Dermatol."},{"key":"B360","doi-asserted-by":"publisher","first-page":"291","DOI":"10.2147\/CCID.S100802","article-title":"Paraneoplastic Pemphigus: a Short Review","author":"Czernik","year":"2016","journal-title":"Ccid"},{"key":"B361","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/j.1365-2230.1993.tb02175.x","article-title":"IgG Subclasses in Pemphigus in Indian and UK Populations","volume":"18","author":"Wilson","year":"1993","journal-title":"Clin. Exp. Dermatol."},{"key":"B362","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/s0306-9877(97)90277-2","article-title":"Gaining More Insight into the Pathomechanisms of Thiol-Induced Acantholysis","volume":"48","author":"Wolf","year":"1997","journal-title":"Med. Hypotheses"},{"key":"B363","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1684\/ejd.2013.2177","article-title":"The Imbalance of Th17 and Regulatory T Cells in Pemphigus Patients","volume":"23","author":"Xu","year":"2013","journal-title":"Eur. J. Dermatol."},{"key":"B364","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1111\/j.1346-8138.2007.00373.x","article-title":"Pemphigus Vulgaris Following Antirabies Vaccination","volume":"34","author":"Yal\u00e7in","year":"2007","journal-title":"J. Dermatol."},{"key":"B365","doi-asserted-by":"publisher","first-page":"5615","DOI":"10.4049\/jimmunol.0901691","article-title":"Antibodies to the Desmoglein 1 Precursor Proprotein but Not to the Mature Cell Surface Protein Cloned from Individuals without Pemphigus","volume":"183","author":"Yamagami","year":"2009","journal-title":"J. Immunol."},{"key":"B366","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1111\/j.1365-2133.2012.11040.x","article-title":"Association between HLA\u2010DRB1 Polymorphisms and Pemphigus Vulgaris: a Meta\u2010analysis","volume":"167","author":"Yan","year":"2012","journal-title":"Br. J. Dermatol."},{"key":"B367","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1046\/j.1365-2133.2000.03604.x","article-title":"Subcorneal Pustular Dermatosis Type of IgA Pemphigus: Demonstration of Autoantibodies to Desmocollin-1 and Clinical Review","volume":"143","author":"Yasuda","year":"2000","journal-title":"Br. J. Dermatol."},{"key":"B368","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3389\/fmed.2019.00249","article-title":"Paraneoplastic Pemphigus Revealed by Anti-programmed Death-1 Pembrolizumab Therapy for Cutaneous Squamous Cell Carcinoma Complicating Hidradenitis Suppurativa","volume":"6","author":"Yatim","year":"2019","journal-title":"Front. Med."},{"key":"B369","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1200\/JCO.2008.18.0182","article-title":"Hepatitis B Virus Reactivation in Lymphoma Patients with Prior Resolved Hepatitis B Undergoing Anticancer Therapy with or without Rituximab","volume":"27","author":"Yeo","year":"2009","journal-title":"JCO"},{"key":"B370","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/intimm\/dxr020","article-title":"Antigen-independent Development of Foxp3+ Regulatory T Cells Suppressing Autoantibody Production in Experimental Pemphigus Vulgaris","volume":"23","author":"Yokoyama","year":"2011","journal-title":"Int. Immunol."},{"key":"B371","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.jdermsci.2016.12.010","article-title":"Non-pathogenic Pemphigus Foliaceus (PF) IgG Acts Synergistically with a Directly Pathogenic PF IgG to Increase Blistering by p38MAPK-dependent Desmoglein 1 Clustering","volume":"85","author":"Yoshida","year":"2017","journal-title":"J. Dermatol. Sci."},{"key":"B372","doi-asserted-by":"publisher","first-page":"139","DOI":"10.4172\/2155-9899.1000139","article-title":"Neutrophil Extracellular Traps and Systemic Lupus Erythematosus","volume":"4","author":"Yu","year":"2013","journal-title":"J. Clin. Cel Immunol"},{"key":"B373","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1002\/art.40937","article-title":"Predicting Severe Infection and Effects of Hypogammaglobulinemia during Therapy with Rituximab in Rheumatic and Musculoskeletal Diseases","volume":"71","author":"Yusof","year":"2019","journal-title":"Arthritis Rheumatol."},{"key":"B374","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1111\/j.1468-3083.2010.03939.x","article-title":"Pemphigus Vegetans: a Clinical, Histological, Immunopathological and Prognostic Study","volume":"25","author":"Zaraa","year":"2011","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"B375","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/pde.12859","article-title":"Neonatal Autoimmune Blistering Disease: A Systematic Review","volume":"33","author":"Zhao","year":"2016","journal-title":"Pediatr. Dermatol."},{"key":"B376","first-page":"79","article-title":"Association between HLA-DRB1, DQB1 Genes and Pemphigus Vulgaris in Chinese Hans","volume":"20","author":"Zhou","year":"2003","journal-title":"Zhonghua Yi Xue Yi Chuan Xue Za Zhi"},{"key":"B377","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.jid.2019.07.717","article-title":"Autoreactive B Cell Differentiation in Diffuse Ectopic Lymphoid-like Structures of Inflamed Pemphigus Lesions","volume":"140","author":"Zhou","year":"2020","journal-title":"J. Invest. Dermatol."},{"key":"B378","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1084\/jem.20091777","article-title":"IL-21 Regulates Germinal center B Cell Differentiation and Proliferation through a B Cell-Intrinsic Mechanism","volume":"207","author":"Zotos","year":"2010","journal-title":"J. Exp. Med."},{"key":"B379","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1016\/j.jid.2021.01.030","article-title":"The Pathogenic Role of CD4+ Tissue-Resident Memory T Cells Bearing T Follicular Helper-like Phenotype in Pemphigus Lesions","volume":"141","author":"Zou","year":"2021","journal-title":"J. Invest. Dermatol."},{"key":"B380","doi-asserted-by":"publisher","first-page":"102366","DOI":"10.1016\/j.autrev.2019.102366","article-title":"Next-generation Fc Receptor-Targeting Biologics for Autoimmune Diseases","volume":"18","author":"Zuercher","year":"2019","journal-title":"Autoimmun. Rev."}],"container-title":["Frontiers in Molecular Biosciences"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2021.808536\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T22:00:36Z","timestamp":1674684036000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2021.808536\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,4]]},"references-count":380,"alternative-id":["10.3389\/fmolb.2021.808536"],"URL":"https:\/\/doi.org\/10.3389\/fmolb.2021.808536","relation":{},"ISSN":["2296-889X"],"issn-type":[{"value":"2296-889X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,4]]},"article-number":"808536"}}